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Resumo 
 
Staphylococcus aureus são agentes patogénicos oportunistas e representam uma das 
causas mais frequentes de infeções adquiridas na comunidade e nosocomiais. S. aureus tem 
desenvolvido vários mecanismos que conduziram à seleção de estirpes mais resistentes. Estas 
bactérias potencialmente letais constituem uma grande ameaça para a saúde pública, sendo que 
o desenvolvimento de novos fármacos para combater este problema mundial é prioritário. No 
entanto, diversos aspetos referentes a esta bactéria têm escapado à atenção, tais como o seu 
metabolismo energético e os seus enzimas respiratórios. Assim, visando alargar este 
conhecimento, as proteínas malato:quinona oxidoreductases foram exploradas a níveis 
moleculares e celulares.  
As malato:quinona oxidoreductases são proteínas membranares, envolvidas no ciclo do 
ácido cítrico e na cadeia respiratória. Estas proteínas catalisam a oxidação de malato a 
oxaloacetato e a concomitante redução da quinona a quinol, fornecendo eletrões à cadeia 
respiratória. S. aureus possui dois genes anotados que codificam duas malato:quinona 
oxidoreductases, MQO I e MQO II, no entanto as diferenças entre ambas são desconhecidas. 
Uma caracterização bioquímica preliminar foi realizada bem como uma extensa investigação 
celular. Pela primeira vez, estas duas proteínas de S. aureus foram purificadas. A MQO I 
apresentou atividade malato:quinona oxidoreductase, contrariamente à MQO II que revelou 
atividade com lactato. O impacto da MQO I no metabolismo de S. aureus foi avaliado, através de 
crescimentos bacterianos com diferentes fontes de carbono, da estirpe selvagem e de um 
mutante. Os metabolitos extracelulares, recolhidos ao longo dos diversos crescimentos, foram 
analisados por espectroscopia RMN, que revelou a incapacidade da estirpe mqoI::Tn em 
catabolizar acetato. Esta abordagem possibilitou também pela primeira vez, uma profunda 
caracterização do comportamento de S. aureus sob diferentes fontes de carbono. Em suma, os 
nossos resultados sugerem que a MQO II, é uma lactato:quinona oxidoreductase, e revelaram a 
importância da MQO I neste patogénico, indicando-a como possível alvo terapêutico.  
 
Palavras-chave: Metabolismo energético; enzimas respiratórios; malato:quinona 
oxidoreductases; cadeia respiratória; espectroscopia RMN.  
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Abstract 
 
Staphylococcus aureus are opportunistic pathogens and represent one of the most 
frequent causes for community acquired and nosocomial infections. Over time, S. aureus has 
developed several mechanisms which led to the selection of increasingly resistant strains. These 
potentially lethal bacterial pathogens have become a major public health threat, being urgent the 
development of new drugs against this worldwide problem. However, and intriguingly many 
fundamental aspects of S. aureus have escaped attention, such as its energy metabolism and 
respiratory enzymes. We aim to contribute to this knowledge by exploring malate:quinone 
oxidoreductases at molecular and cellular levels. 
Malate:quinone oxidoreductases are membrane-bound proteins, involved in both the 
citric acid cycle and in the respiratory chain. These proteins catalyse the oxidation of malate to 
oxaloacetate and the reduction of quinone to quinol, providing electrons to the respiratory chain. 
S. aureus has two annotated genes encoding for two malate:quinone oxidoreductases, MQO I 
and MQO II, although the differences between these proteins are not known. Preliminary 
biochemical characterization and a thorough cellular investigation were performed in this work. 
For the first time, both proteins from S. aureus were purified. MQO I presented malate:quinone 
oxidoreductase activity, contrarily to MQO II which showed activity with lactate. The impact of the 
role of MQO I in S. aureus metabolism was evaluated by growths of a wild-type strain and of one 
mutant strain under different carbon sources. An NMR metabolomics approach was used to 
analyse the excreted metabolites along the growths, suggesting the inability of mqoI::Tn to 
catabolize acetate. This approach also provided, for the first time, a deep characterization of the 
wild-type strain, under different carbon sources. Our results suggest a misassignment of MQO II, 
being probably a lactate:quinone oxidoreductase and highlight the relevance of MQO I in this 
pathogen, making it an attractive candidate for targeted therapeutics.  
 
Keywords: Energy metabolism; respiratory enzymes; malate:quinone oxidoreductases; 
respiratory chain; NMR metabolomics. 
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1. Introduction 
1.1. Energetic Metabolism  
1.1.1. Energy at the basis of Life 
The study of Life Sciences requires the knowledge of Bioenergetics. Life is nothing less 
than a result of energy changes. Energy is the main requirement for survival, and the evidence is 
that all biochemical processes involve energy transfer.  
Living cells exchange matter and energy with their surroundings, obtaining and 
conserving energy in order to survive, grow, reproduce and preserve their structures, maintaining 
the dynamic equilibrium.  
Bioenergetics is an extensive scientific domain, which concerns the study of energy 
transformations in living systems.  
 In vertebrates, energy is obtained by oxidative phosphorylation in the mitochondria. The 
Chemiosmotic theory, postulated by Sir Peter Mitchel in 19611 (Nobel Prize for Chemistry, 1978), 
enabled the understanding of many biological energy transduction reactions and processes, such 
as the oxidative phosphorylation, in which the energy of electron flow is conserved by the 
translocation of protons across the membrane, leading to the establishment of a transmembrane 
electrochemical potential – the proton-motive force1,2,3.  
The proton-motive force comprises two different components: the different chemical 
concentrations between both sides of the membrane, and the charge distribution (Δѱ) across the 
inner mitochondrial membrane. Thus, the inherent electrochemical potential is further used by 
ATP synthase for the synthesis of ATP2,4.  
Science is the poetry of reality in which Energy plays the central role. As Albert Einstein 
once said: “Everything is energy and that’s all there is to it”. 
 
1.1.2. Metabolic pathways  
Energy is required for the maintenance of life, reproduction and for the synthesis of cell 
components. This energy is provided by carbohydrates, fatty acids, proteins and vitamins, among 
others. Metabolism is the sum of all the chemical transformations, taking place in a cell or 
organism, through successive enzymatic reactions via specific metabolic pathways. Cellular 
metabolism can be divided into catabolic and anabolic reactions. In the first one (catabolism) 
complex molecules with high energetic value, such as proteins, carbon hydrates and fatty acids, 
are degraded into structurally simpler molecules in a thermodynamically favourable process. In 
anabolic reactions the same molecules are combined and transformed, with energy consumption, 
in higher components2,5. Following the origin of cells, microbial life experienced a long period of 
metabolic diversification, exploiting the various resources available on Earth. 
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In the course of evolution, organisms have acquired a remarkable collection of regulatory 
mechanisms to maintain the homeostasis at the molecular, cellular and organism level. Cells and 
organisms do not live in a static environment; in fact, they exist in a dynamic equilibrium, meaning 
that for each metabolic reaction in a pathway, the substrate produced by the preceding reaction 
is then converted to product2,5,6. However, cells do not live in equilibrium with their surroundings, 
but tend to keep a steady state. Thus, when this is disrupted due to external factors, regulatory 
mechanisms are triggered in order to compensate this disruption. Metabolic pathways are 
regulated at several levels, from within the cell and from outside. This regulation occurs essentially 
at two levels: the control of enzyme synthesis and the variation of enzyme activity. The control of 
enzyme synthesis is due to the availability of substrate, while the second one is relative to the 
allosteric regulation, by metabolic intermediates or coenzymes that signal the cell’s internal 
metabolic state. These signals allow the allosteric inhibition of one or more enzymes involved in 
the respective metabolic pathway, when its consumption is not needed2,5,3.   
Glucose has a central role in the metabolism of animals, plants and many organisms. 
Besides being an excellent source of energy used to produce ATP, glucose is also an important 
precursor, able to supply an extensive array of metabolic intermediates for biosynthetic reactions. 
A molecule of glucose is converted into two molecules of pyruvate by a series of enzyme-
catalysed reactions, in a metabolic process denominated as glycolysis. Glycolysis is the central 
pathway of glucose catabolism, presenting the largest flux of carbon in most cells. In this process, 
some of the free energy released from glucose degradation is conserved in the form of ATP and 
NADH2,5,6,7. 
𝐺𝑙𝑢𝑐𝑜𝑠𝑒 + 2𝑁𝐴𝐷+ + 2𝐴𝐷𝑃 + 2𝑃𝑖 → 2 𝑝𝑦𝑟𝑢𝑣𝑎𝑡𝑒 + 2𝑁𝐴𝐷𝐻 + 2𝐻
+ + 2𝐴𝑇𝑃 + 2𝐻2𝑂   
Equation 1 – Overall equation for glycolysis. For each molecule of glucose degraded to pyruvate, are 
generated two molecules of ATP. 
The conversion into pyruvate represents a fundamental step in the intermediary 
metabolism, because it corresponds to the branch point for synthetic and catabolic reactions2,7.  
Pyruvate produced from glycolysis can be further metabolized by different catabolic routes. It can 
be reduced to lactate, accepting electrons from NADH and thus regenerating NAD+, in a process 
named lactic acid fermentation. This process occurs under anaerobic conditions but it can be 
even observed under aerobiosis, depending on the microorganisms and cell types2,5. Ethanol and 
CO2 can also be generated from pyruvate under hypoxic or anaerobic conditions, via alcohol 
fermentation. Under aerobic conditions, pyruvate is oxidized to produce the acetyl group of acetyl-
coenzyme A which is further oxidized to CO2 by the enzymes of the citric acid cycle, where the 
energy released is temporarily conserved in the electron carriers – nicotinamide adenine 
dinucleotide (NADH) or quinones. These are oxidized, and their respective electrons pass through 
a chain of electron-carrying molecules in the mitochondria (respiratory chain) to the final electron 
acceptor, oxygen (Figure 1.1).  
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The citric acid cycle (Figure 1.2) is a key metabolic pathway that takes place in the matrix 
of the mitochondria in eukaryotic organisms or in the cytosol of prokaryotes. Acetyl-CoA enters in 
this cyclic pathway through its condensation with oxaloacetate, by citrate synthase, producing 
citrate. This process represents the first of eight sequential reactions that characterize the citric 
acid cycle. For each molecule of Acetyl-CoA oxidized, the pathway produces three molecules of 
NADH, one molecule of quinol and one of ATP2,5,6. The citric acid cycle also provides precursors 
for many biosynthetic pathways, playing an important role in the metabolism. For example, α-
Ketoglutarate and oxaloacetate are able to serve as precursors of aspartate and glutamate2,6.  
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Figure 1. 1 - Schematic representation of catabolism of proteins, fatty acids and carbohydrates of cellular 
respiration adapted from Nelson MC. Lehninger Principles of Biochemistry. 
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1.1.3. Respiratory chains 
As the diversity of Life, respiratory chains also present a large diversification depending 
on the organism and on its respective metabolic needs. Thus, evolution has witnessed changes 
in the respiratory chains8.  
The respiratory chain is composed of a number of protein complexes capable of transport 
electrons. In addition, some complexes also translocate protons across the membrane against 
the electrochemical gradient (Figure 1.3). These respiratory chain proteins differ according to the 
organism. In prokaryotic organisms the expression occurs in the cellular membrane, while in the 
eukaryotes the proteins are expressed in the inner mitochondrial membrane. In the first case, the 
proteins translocate protons from cytoplasm to periplasmic space, and in the second the protons 
are translocated from the mitochondrial matrix to the inter-membrane space8.  
 The best characterized Electron Transfer Chain (ETC) is the mammalian one. The 
respiratory chain of mammalian mitochondria is an assembly of several electron carriers that are 
mainly grouped into multi-polypeptide complexes. It is described as comprising four complexes 
(Complex I, II, III and IV) and the mobile electron carriers, ubiquinone and cytochrome c (cyt c), 
that guarantee the electron transfer between the complexes3,4.  
NADH:ubiquinone oxidoreductase (Complex I, CpI) is one of the enzymes that provides 
electrons to the respiratory chain of mitochondria and several bacteria. This complex (EC:1.6.5.3) 
is also the largest one, with approximately 1 MDa and constituted by 44 subunits. CpI catalyses 
the transfer of two electrons between NADH and ubiquinone (UQ), which is reduced to ubiquinol 
Figure 1. 2 – Schematic representation of the citric acid cycle reactions, adapted from Nelson MC. Lehninger 
Principles of Biochemistry.  
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(UQH2). The complex also functions as a proton pump, thus this redox transfer is coupled to the 
translocation of protons across the membrane, from the mitochondrial matrix to the 
intermembrane space, contributing in this way to the maintenance of the transmembrane 
electrochemical potential2,9,10.  
Complex II (CpII), also called succinate:quinone oxidoreductase (EC 1.3.5.1) catalyses 
the two-electron oxidation of succinate to fumarate, and subsequently the reduction of the 
ubiquinone to ubiquinol, similarly to Complex I. However, unlike CpI the catalytic reaction 
performed by CpII is not coupled to charge translocation4,11.  
Electrons are further transferred from ubiquinol to cytochrome c, by Complex III (CpIII, 
ubiquinol:cytochrome c oxidoreductase), in a reaction coupled to the transport of protons from the 
matrix to the intermembrane space. Translocation of protons occurs through a Q-cycle 
mechanism, which accommodates the switch between the two-electron carrier, ubiquinone, and 
the one-electron carrier, cytochrome c. One electron is provided, per ubiquinol molecule oxidized, 
through an iron sulphur cluster, to reduce cytochrome c. The second electron is used to reduce 
ubiquinone. Thus, a complete Q-cycle requires the oxidation of two ubiquinol molecules, resulting 
in the translocation of four protons to the positive side of the membrane, contributing to the 
generation of the membrane potential: 2 protons per each reduced cytochrome. This dimeric 
transmembrane protein complex III (EC:1.10.2.2), also called cytochrome bc1 complex, presents 
11 subunits per monomers and is composed of a cytochrome c1, a cytochrome b and a Rieske 
iron-sulfur subunit2,12. After accepting an electron from the CpIII, the reduced cytochrome c 
donates electrons to Complex IV (cytochrome c oxidase).  
Complex IV (EC:1.9.3.1) performs the oxidation of four cytochrome c molecules, reducing 
oxygen and leading to the production of H2O. During the reduction of O2 to H2O, this large complex 
with 13 subunits pumps four protons across the membrane, to the intermembrane space3,13. 
Figure 1. 3 – Schematic representation of proteins and electron carriers involved in respiratory chains, 
adapted from Marreiros et al, 2016. A - Transmembrane proteins with X:quinone oxidoreductase activity, B 
- Cytoplasmic facing monotopic proteins with X:quinone oxidoreductase activity. C - Periplasmic facing 
monotopic proteins with X:quinone oxidoreductase activity. D - Transmembrane proteins with quinol:soluble 
electron carrier oxidoreductase activity. E - Soluble electron carrier that is reduced by D and is oxidized by 
F. F - Transmembrane proteins with quinol:terminal electron acceptor or soluble electron carrier:terminal 
acceptor (Y) oxidoreductase activity. G - Transmembrane proteins with oxidoreductase activity with no 
interaction with quinones. (+ and – indicate the positive and negative sides of the transmembrane difference 
in electrochemical potential, respectively). 
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Prokaryotic organisms have the ability to survive under different conditions, due to the 
diversity of their energetic metabolism that allows the capability of living even in primitive 
environments. The respiratory chains of prokaryotes may include similar complexes to the 
mammalian ones but different in several points, for example in the respiratory proteins, presenting 
fewer polypeptide chains. However, prokaryotes are able to use oxygen, iron, sulphur, nitrogen 
compounds or even organic metabolites as final electron acceptors. Respiratory chains of 
prokaryotes show thus remarkable diversity, flexibility and robustness, containing several electron 
entry branch points and comprising enzymes with apparently the same functions, such as 
malate:quinone oxidoreductases (MQO), the focus of this thesis4,8.  
 
 
1.1.4. Malate:quinone oxidoreductase 
Several bacteria possess membrane-bound dehydrogenases other than cytosolic 
dehydrogenases in their respiratory chains, such as the membrane-bound malate:quinone 
oxidoreductase (MQO) which has a fundamental role for bacterial growth. According to the 
literature, this protein is described in the three domains of life, Eukarya (5%), Bacteria (27%) and 
Archaea (9%)4. 
Malate:quinone oxidoreductase (EC 1.1.5.4), like CpII, is part of both citric acid cycle and 
of the respiratory chain4. Malate:NAD+ oxidoredutase (EC 1.1.1.37), MDH catalyses the same 
reaction as MQO in the TCA cycle14. 
MQO was first described by David Cohn in Micrococcus lysodeikticus, in 195815 and, 
since then, it has been described in several other prokaryotic organisms, namely in Bacillus sp. 
PS316, Helicobacter pylori 17, Corynebacterium glutamicum18,19 and E. coli14.  
MQO is a membrane bound protein, encoded by the gene mqo, and contains a Flavin 
adenine dinucleotide (FAD) as prosthetic group (Figure 1.4). As MDH, this protein catalyses the 
oxidation of malate to oxaloacetate, but in contrast to MDH, it donates electrons from malate 
oxidation to quinones, reducing quinone to quinol, providing directly electrons to the Electron 
Transfer Chain3,4,16,17,14.  
MQO has been overlooked, although it has been described as a monotopic enzyme 
localized at the surface of the lipid bilayer through electrostatic or hydrophobic interactions17. 
Presenting a FAD as a prosthetic group, the oxidized flavin accepts two electrons from the 
substrate (malate) yielding the reduced state, FADH2. The presence of FAD gives the 
characteristic yellow color to the protein, corresponding to a maximum absorption at 450 nm in 
the absorption UV Visible spectrum (Figure 7.1 in Supplemental Material) with an extinction 
coefficient (ε) of 11.3 mM-1 cm-1 20. 
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The absence of MQO in mammalian cells makes this protein a potential drug target for 
the production of pharmaceutical agents against some pathogenic microorganisms, in which 
MQO is the only malate oxidase present16. For that reason, it is also important to understand the 
mechanism of this protein, its interaction with the substrates and its impact on microorganisms’ 
metabolism.  
MQOs from Staphylococcus aureus (S. aureus) were the systems under study in this 
thesis. 
 
1.2. Staphylococcus aureus 
1.2.1. General characteristics 
Staphylococcus aureus (S. aureus) strains are potentially lethal bacterial pathogens that 
have been considered a serious worldwide threat to public health due to its multiple drug 
resistance to the antibiotics, capable to cause several infections21,22,23. For this reason, S. aureus 
strains have been extensively studied.  
This organism belongs to the Firmicutes phylum and is a facultative anaerobic Gram-
positive bacterium. Staphylococci are nonsporulating cocci with a diameter of approximately 0.5-
1.5 µm, that divide in multiple planes in order to produce irregular clumps of cells6. 
S. aureus are opportunistic pathogens that can be frequently found in the human 
respiratory tract and in the skin, representing one of the most frequent causes for community 
acquired and nosocomial infections6,21. The most common features caused by this pathogen are 
skin infections, but it also frequently to causes pneumonia, sepsis episodes, endocarditis and 
osteomyelitis24.  
In the US more than 50 % of all S. aureus isolates causing clinical diseases are Methicillin-
Resistant Staphylococcus aureus (MRSA) strains. These strains present resistance to β-lactam 
Figure 1. 4 – Schematic representation of malate:quinone oxidoreductase, a monotopic protein facing the 
periplasm, that catalyses the oxidation of malate into oxaloacetate and reducing the quinone to quinol. FAD 
is represented by the three rings. (+ and – indicate the positive and negative sides of the transmembrane 
difference in electrochemical potential, respectively). Adapted from Marreiros et al, 2016. 
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antibiotics, including methicillin, a penicillin. Resistance to methicillin occurs through the 
acquisition of the mecA gene, located in the staphylococcal cassette chromosome mec 
(SCCmec)21. MRSA is one of the major hospital-associated pathogens (HA-MRSA). Initially, 
these strains affected people with chronic diseases and hospitalized patients, but nowadays 
healthy individuals began to be affected as well in all the community (CA-MRSA) around the 
world22. Thus, over time these strains quickly led to epidemic CA-MRSA infections with serious 
consequences and high mortality rates. Currently, the existence of more than 20 distinct genetic 
lineages of CA-MRSA is known, but the outbreaks associated with each one varies according to 
the different clones. USA 300 is one of the most epidemic strains and it has already been reported 
in 50 different countries21,24,22. In addition, there are other types of S. aureus strains causing lower 
levels of mortality comparing to the MRSA ones, the methicillin-susceptible Staphylococcus 
aureus (MSSA).  
Portugal represents the country in Europe with the highest rate of MRSA in nosocomial 
infections22. This high frequency of MRSA seems to result mainly from dissemination from the 
hospitals. Data from 2013 showed that the highest prevalence was found in the northern region 
(Oporto and Braga) followed by the Lisbon district22. 
Due to the increased incidence of S. aureus’ drug resistance, the treatment for these 
opportunistic pathogen infections is urgent and has become a therapeutic challenge. 
 
1.2.2. Virulence mechanism  
The pathogenicity of S. aureus is mainly determined by the secretion of several virulence 
factors, such as enzymes, toxins, adhesions and immunomodulators that allow the pathogen to 
colonize and interact with the host cells, causing cell destruction21,25.  
Almost all CA-MRSA strains carry Panton-Valentine leukocidin (PVL) genes, as well as 
MSSA strains, but with small expression levels. PVL is a cytotoxin that forms pores in the 
membranes of leukocytes, specifically in neutrophils, causing cell lysis leading to a leukocyte 
destruction and tissue necrosis26.  
Another virulence factor in S. aureus is α-toxin. This cytotoxic agent lysis immune system 
cells, such as macrophages and lymphocytes, and is able to modify the platelet morphology, 
leading to thrombotic problems21.  
These are the most studied S. aureus’ virulence factors. Nonetheless, the pathogen 
possesses several others which are responsible for its high pathogenicity21.  
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1.2.3. Metabolic pathways of S. aureus 
The major metabolic pathways are almost identical in all living organisms, but there are 
a few groups of bacteria in which some systems are modified2,5,6. 
S. aureus is a facultative anaerobic bacteria able to perform both aerobic and anaerobic 
respiration. Under aerobic conditions the pathogen uses oxygen as final electron acceptor, 
otherwise under anaerobic environments S. aureus can grow by fermentation or nitrate 
respiration27. This ability to adapt to different conditions allows the colonization of the pathogen, 
from the skin or nasal cavity to the internal host niches, where the availability of free oxygen 
diminishes27,28,29. S. aureus uses the pentose phosphate and glycolytic pathways to catabolize 
glucose. It also uses the citric acid cycle and the amino acids catabolism to obtain energy but it 
is not able to metabolize fatty acids, since according to the annotated genome sequence, S. 
aureus lacks the enzymes necessary for β-oxidation30,31. 
S. aureus must rapidly adapt to a diversity of carbon sources during host invasion. The 
fast metabolic adaptation of this opportunistic pathogen provides it with greater pathogenicity 
when compared to other innocuous staphylococci in humans32. This versatile capability to adapt 
to different conditions is associated with its bioenergetic metabolism. Nevertheless, even though 
it is a prominent human pathogen, its respiratory enzymes have been escaping attention. S. 
aureus expresses several quinone reductases that feed electrons to the respiratory chain at 
different metabolic points, whether using O2 or nitrate as electron acceptors.  
 
1.2.4. Respiratory chain of S. aureus  
The knowledge of the S. aureus respiratory chain is very limited. S. aureus is able to 
perform both aerobic and anaerobic respiration27,28,29.  
The genome of this pathogen does not reveal any gene cluster encoding Complex I 
(http://www.sanger.ac.uk/resources/downloads/bacteria/staphylococcus-aureus.html).  This 
means that NADH oxidation has to be performed by an alternative respiratory enzyme. Type 2 
NADH:quinone oxidoreductase (NDH-2) plays this role33. Also, instead of reducing NADH, 
electrons may be fed directly to the respiratory chain, via quinones.   
Besides two NDH-2, S. aureus has more genes coding for quinone reductases present 
in its genome, such as Malate:quinone oxidoreductase (OR), MQO; Lactate:quinone OR, LQO; 
Pyruvate:quinone OR, PQO; Succinate:quinone OR, SDH; Glycerol-3-phosphate:quinone OR, 
G3PDH; Sulfide:quinone OR, SQR; Dihidroorotate:quinone OR, DHODH and the so-called MPS 
(membrane potential-generating system)4. These allow a direct link between different metabolic 
pathways and the respiratory chain. Figure 1.5 shows a schematic representation of S. aureus 
cell highlighting the central carbon metabolism and the quinone reductases present in S. aureus’ 
respiratory chain.  
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1.2.5. Malate:quinone oxidoreductases  
Several bacteria possess membrane-bound dehydrogenases instead of cytosolic 
dehydrogenases in their respiratory chains, such as the membrane-bound malate:quinone 
oxidoreductases (MQOs).  
The malate:quinone oxidoreductase (EC 1.1.5.4) from S. aureus is a respiratory enzyme 
that catalyses the transfer of two electrons from malate to menaquinone. This pathogen presents 
two genes encoding two different MQOs, mqoI and mqoII, which are referred as MQO I and MQO 
II, respectively 34. Despite not being yet understood the differences between the two copies, the 
first one is described as a malate:quinone oxidoreductase, originally annotated as a MQO I, with 
a molecular mass equivalent to 57 kDa. Preliminary studies indicate that this S. aureus’ enzyme 
has a flavin adenine dinucleotide (FAD) and lipid-dependent peripheral membrane protein34,35. 
However, further biochemical studies are needed. 
The second copy of MQO from S. aureus was originally annotated as malate:quinone 
oxidoreductase II with approximately 56 kDa, although its function remains unknown. Recent 
studies revealed that MQO II has affinity to the substrate lactate, instead to malate, suggesting a 
new function to the second copy34.  
Despite the differences, published studies also revealed that both copies have an 
important role in S. aureus’ respiratory chain and survival34,35,36. Another important fact is the 
Figure 1. 5 - Brief schematic representation of quinone reductases present in S. aureus’ respiratory chain 
and metabolic pathways, adapted from Marreiros et al, 2016. In the grey box is represented the membrane, 
with the monotopic quinone reductases. 1 – NDH-2-A; 2 – PQO; 3 – MQO; 4 – DHODH; 5 – SQR; 6 – SDH; 
7 – LQO; 8 – G3PDH; 9 – NDH-2-B; 10 – MPS. 
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absence of the gene coding for the soluble MDH in this microorganism34, which is also capable 
of oxidizing malate into oxaloacetate; Thus, without this enzyme the oxidation of malate is only 
dependent on the activity of MQO. Therefore, the study of these proteins (MQO I and II) is 
promising and challenging since they are poorly biochemically characterized; For example no 
crystallographic structure is available. Also, since S. aureus presents two copies of MQO, it is 
important to know the cellular role of these enzymes.  
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2. Aims 
 
This project aimed to contribute to the knowledge of S. aureus’ energetic metabolism by 
exploring respiratory enzymes, namely malate:quinone oxidoreductases, at molecular and 
cellular levels. Specifically, our objectives were:  
 Expression, purification and biochemical characterization of the two malate:quinone 
oxidoreductases, MQO I and MQO II, from S. aureus;  
 Investigation of the function of both MQO I and MQO II; 
 Explore the impact of MQO I in the metabolism of S. aureus; 
 Characterization of S. aureus behaviour under different carbon sources.  
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3. Materials and Methods 
3.1. Molecular Studies 
3.1.1. Cloning and Protein Expression 
The genes SAI6T6_1017480 and SAI6T6_1019420 encoding S. aureus ST228/18341 
(MRSA) MQO I and MQO II, respectively, were individually cloned into plasmid pET-28a(+) 
(GenScript). The gene product MQO I corresponds to a protein of 511 amino acid residues, while 
MQO II presents 498 residues, with theoretical molecular masses of approximately 57 kDa and 
56 kDa, respectively. The plasmid DNA was extracted using the Wizard® Plus SV Minipreps DNA 
Purification System (Promega) and competent cells, Escherichia coli (E. coli) C43(DE3) cells 
(Lucigen) and E. coli Rosetta 2 (DE3) pLysS cells (Novagen), were prepared. Transformation was 
achieved using a heat shock protocol37. E. coli C43 and Rosetta 2 cells, were transformed with 
the vector mqoI-S. aureus and grown, respectively, in Luria Bernati (LB) medium supplemented 
with 50 µg mL-1 kanamycin (Roth), or in 2×YT-rich medium supplemented with 100 µg mL-1 
kanamycin (Roth) and 34 µg mL-1 chloramphenicol (Roth), at 37 ⁰C and 180 rpm. Several 
expression conditions were tested, some of which prior to the beginning of the project. Most 
promising gene expressions were induced with 0.5 mM or 1 mM IPTG (isopropyl β-D-1-
thiogalactopyranoside) (Apollo Scientific) when the cells reached an optic density at 600 nm 
(OD600) of 0.6. The cells were harvested 4 h after induction or after an overnight growth, by 
centrifugation at 8,000 rpm for 10 min, and stored at -20 ⁰C.  
For MQO II, expression tests were performed in the host lab and optimized before the 
beginning of the project. E. coli C43 cells were transformed with the vector mqoII-S. aureus and 
grown in Terrific Broth (TB) medium supplemented with 50 µg mL-1 kanamycin (Roth), at 37 ⁰C 
and 180 rpm. Gene expression was induced with 0.1 mM IPTG (Apollo Scientific) when the cells 
reached an optic density at 600 nm (OD600) of 0.6. The temperature was changed to 18 ⁰C after 
the induction35. Cells were harvested after an overnight growth, by centrifugation at 8,000 rpm for 
10 min, and stored at -20 ⁰C. 
 
3.1.2. Protein Purification 
Cells were resuspended in 20 mM Tris-HCl buffer pH 7.8, 10 % glycerol, 250 mM NaCl, 
or 100 mM K2HPO4/KH2PO4 pH 7.0, 250 mM NaCl, both containing one complete protease-
inhibitor cocktail tablet (Roche). Cells were disrupted in a French press at 41.4 MPa and cellular 
debris and undisrupted cells were separated out by centrifugation at 10,000 rpm, 10 min. The 
membrane fraction was ultracentrifuged at 42,000 rpm, and different times were tested: for 2 h, 4 
h and overnight. Several experiments were also performed in order to remove the protein from 
the membrane; these included tests with sodium chloride (NaCl) and with detergent DDM (n-
Dodecyl β-maltoside) (Glycon), varying the concentrations of each. In some trials, the membrane 
pellet was resuspended using a Potter homogenizer in 100 mM K2HPO4/KH2PO4 buffer pH 7.0, 2 
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M NaCl, and incubated overnight at 4 ⁰C, under agitation. In another approach the membrane 
pellet was resuspended with a Potter homogenizer in 20 mM Tris-HCl buffer pH 7.8, 10 % glycerol, 
500 mM NaCl, 0.1 % ethylenediaminetetraacetic acid (EDTA). DDM was gradually added (3 g of 
detergent per 1 g of protein) and incubated overnight at 4 ⁰C, under agitation. The membrane 
fraction was further ultracentrifuged at 42,000 rpm for 1 h or 3 h, depending on the different 
approaches. NaCl concentration in the supernatant containing the protein of interest was 
decreased to approximately 50 mM NaCl at 4 ⁰C by successive additions of the same buffers 
used in the steps before according to the different trials, but no NaCl. The sample was 
concentrated in an Amicon system (30 000 MWCO).  
The obtained washed membrane fraction was injected in an ion-exchange Q-Sepharose 
High Performance 74 mL column (GE Healthcare) and eluted with a concentration gradient from 
0 to 1 M NaCl in 20 mM Tris-HCl buffer pH 7.8, 10 % glycerol, or in 100 mM K2HPO4/KH2PO4 
buffer pH 7.0. The fraction containing the protein of interest was then injected into a size exclusion 
chromatography column, Gel-filtration Superdex 200 XK 26/60 300 mL column (GE Healthcare) 
and eluted with 20 mM Tris-HCl buffer pH 7.8, 10 % glycerol, 150 mM NaCl or with 100 mM 
K2HPO4/KH2PO4 pH 7.0, 250 mM NaCl. The buffers used contained one complete protease-
inhibitor cocktail tablet (Roche). These two columns were chosen as initial steps of the 
purifications and were common to most of the different experiments, although there were cases 
where more than one injection was needed, depending on the trials. Fractions containing the 
protein of interest, selected by absorption spectroscopy and enzymatic assays, were further 
injected in different columns and different procedures were tested: His-Trap HP 5 mL column (GE 
Healthcare) was used, since it presents affinity for histidines, using as eluent a concentration 
gradient from 20 mM to 300 mM imidazole (Sigma Aldrich). An affinity chromatography Hi Trap 
IMAC HP 5 mL column (GE Healthcare) was also tested, charged with zinc (ZnCl2; MERCK) or 
with cobalt (CoCl2; MERCK), and eluted with a concentration gradient from 5 mM to 250 mM of 
L-Histidine (Roth). An anion exchanger Mono Q 5/50 GL column (GE Healthcare) was used in 
some purification trials, and the elution step was performed with a concentration gradient from 0 
to 1 M NaCl in 100 mM K2HPO4/KH2PO4 buffer pH 7.0. Chromatography columns were operated 
by an AKTA Prime Plus system (GE Healthcare) and detection was monitored by the change in 
absorbance at 280 nm. All the protein fractions were stored at -20 ⁰C.  
The described procedures were applied to both MQO I and MQO II. 
 
3.1.3. Biochemical and Biophysical Characterization  
3.1.3.1. Protein purity assessment  
Protein purity of the different samples was analysed by sodium dodecyl sulphate – 
polyacrylamide gel electrophoresis (SDS-PAGE) using a Mini-PROTEAN® Electrophoresis 
System from BIORAD.  Samples were diluted in 5 µL of loading buffer (Tris-HCl 50 mM, pH 8; 
SDS; Bromophenol Blue; Glycerol; β-mercaptoethanol and Urea) and were subsequently injected 
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in a 15 % acrylamide stacking and resolving gel. Precision Plus Protein™ Dual Color (BIORAD) 
and Low Molecular Weight (LMW) standards (GE Healthcare) were used ranging from 10 to 280 
kDa and from 14 to 97 kDa, respectively. Electrophoreses were carried out at 180 V, 400 mA, 
200 W for 1 h. Gels were revealed using Blue Coomassie Stainer and destaining solution in order 
to observe the protein bands.  
3.1.3.2. Absorption spectroscopy 
UV-Visible absorption spectroscopy was used to evaluate the fractions resulting from the 
purification steps. UV-Visible absorption spectroscopy was performed on a Shimadzu UV-1800 
spectrophotometer, at room temperature, using a wavelength range from 250 to 750 nm.  
Absorption spectroscopy was also used to characterize the different reduction states of 
the protein. Spectra were collected on a spectrometer placed inside an anaerobic chamber (Coy 
Laboratory Products) with an O2 level below 1 ppm. All solutions were prepared inside the 
anaerobic chamber with degassed water to guarantee the absence of oxygen. Reduction of 4.6 
µM MQO II was achieved by addition of sodium dithionite (Sigma Aldrich) in a proportion of 1:10. 
Spectra were collected from 250 to 750 nm, in 100 mM phosphate buffer pH 7.0, 250 mM NaCl. 
3.1.3.3. Protein quantification 
Protein concentration was determined by the BCA (bicinchoninic acid assay) Protein 
Assay Reagent (Pierce) using BSA (bovine serum albumin) as standard (Thermo Fisher 
Scientific) according to the respective kit protocol38 or using the Biuret Protein Assay according 
to the protocol39. 
3.1.3.4. Enzymatic studies 
Kinetic assays were performed under anaerobic conditions, in an anaerobic chamber with 
low O2 levels, below 1 ppm. All the solutions were prepared inside the anaerobic chamber with 
degassed water. Each experiment was performed in triplicate at 30 °C and with continuous 
agitation. Each assay started with the addition of the electron acceptor, 150 µM 2,3-dimethyl-1,4-
naphtoquinone (DMN) (synthesized from menadione40 from Sigma Aldrich) or 100 µM 2,6-
dichloroindophenol (DCPIP) (Sigma Aldrich), in 100 mM phosphate buffer pH 7.0, 250 mM NaCl, 
followed by the addition of 15 mM of substrate, Malate (L-malic acid; Sigma Aldrich) or Lactate 
(Potassium L-Lactate; FLUKA), and finally the addition of protein. In some specific cases, 
enzymatic activities were also tested with 150 µM DMN in the presence of 150 µM 2-n-Heptyl-4-
hydroxyquinoline-N-oxide (HQNO) (Alexis Biochemicals). The reactions were monitored by the 
change in the absorbance at 300 nm for DMN or 600 nm for DCPIP.  
Enzymatic assays were also performed in the same conditions, as a screening procedure, 
in order to select fractions containing the protein of interest during the purification steps. 
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3.1.3.5. Protein stability analyses 
In order to study the thermal stability of the protein, thermal denaturation assays were 
performed using a Peltier temperature controller with a rate of 0.5 °C/min between 25 and 90 °C. 
Data was recorded in intervals of 1 ºC with an acquisition time of 0.1 min. Denaturation was 
monitored by fluorescence spectroscopy using two different excitation wavelengths, 450 nm 
(monitoring FAD) and 280 nm (monitoring tryptophan) with emission wavelengths of 530 nm and 
355 nm, respectively. The assays were performed using 2 µM of protein diluted in 100 mM 
phosphate buffer pH 7.0, 250 mM NaCl. 
The Melting Temperature was calculated using the OriginPro8 software, fitting a 
Boltzmann function (sigmoidal curve) to the data. 
 
3.2. Functional Characterization 
3.2.1. Enzymatic activity pH profile 
The kinetic assays at different pH values were performed under anaerobic conditions, in 
an anaerobic chamber with low O2 levels, below 1 ppm. All solutions were prepared only inside 
the anaerobic chamber with degassed water. Enzymatic reactions were evaluated at 600 nm. 
Each experiment was performed in triplicate at 30 °C and with continuous agitation. The 
enzymatic activity was tested at different pH values, namely pH 5.5, pH 6, pH 6.5, pH 7, pH 7.5 
and pH 8, in 50 mM MES (2-(N-morpholino) ethanesulfonic acid) (Roth), 50 mM Bis-Tris Propane 
buffer (Sigma Aldrich), 250 mM NaCl. Each assay started with the addition of 0.1 mM DCPIP 
(Sigma Aldrich), followed by the addition of 15 mM Lactate (Potassium L-Lactate; FLUKA), and 
then of 0.92 µM of protein, MQO II.  
 
3.2.2. Mass Spectrometry analysis  
Proteins were identified by mass spectrometry at the ITQB/IBET MS Unit. Data were 
acquired in a positive reflector MS and MS/MS modes using a 4800 plus MALDI-TOF/TOF (AB 
Sciex) mass spectrometer, using 4000 Series Explorer software v.3.5.3 (Applied Biosystems). 
External calibration was performed using Pepmix1 (Laser BioLabs). 
 
 
3.3. Cellular Studies  
With the aim of understanding the impact of MQO I in the energetic metabolism of 
Staphylococcus aureus, bacterial growths of a wild-type strain and of a mutant with a transposon 
in the gene coding for MQO I, were performed.  
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3.3.1. Bacterial Strains 
The S. aureus strains used were all derived from JE2 (the wild-type strain). The bursa 
aurealis transposon mutant was obtained from the Nebraska Transposon Mutant Library41. S. 
aureus strain JE2 is a plasmid-cured derivative of strain LAC that was isolated in 2002 from a 
skin and soft tissue infection of an inmate in the Los Angeles County Jail in California, USA. Strain 
JE2 is a methicillin-resistant S. aureus (MRSA) strain and is a USA300 isolate. 
Staphylococcus aureus transposon mutant NE1381 (SAUSA300_2541) was created by 
disruption of mqoI, the gene coding for malate:quinone oxidoreductase I. This transposon mutant 
was derived from S. aureus strain JE2. Mutagenesis occurred through the use of the mariner-
based transposon (Tn) bursa aurealis resulting in an erythromycin-resistant deletion strain of 
JE242. This mutant strain is mentioned throughout this thesis as mqoI::Tn. 
 
3.3.2. Confirmation of the Mutation mqoI::Tn 
In order to verify the location of the transposon insertion in the gene coding for MQO I 
(SAUSA300_2541), we used specific primers. Therefore, the forward primer (5’-
CTCGATTCTATTAACAAGGG-3’) was used to hybridize with the bursa aurealis transposon while 
the reverse primer was the gene-specific primer (5’-GGCTCCAATTAAAACGATG-3’) to generate 
a polymerase chain reaction (PCR) product. The PCR product size was confirmed by an agarose 
gel electrophoresis. 
 
3.3.3. Cell Growth 
Staphylococcus aureus strains obtained from the Nebraska Transposon Mutant Library 
were grown in Tryptic Soy Agar (TSA) (Difco) plates, containing 15 g L-1 agar, incubated overnight 
at 37 ⁰C. Precultures were inoculated with a single colony, from the correspondent TSA plate, 
grown for 14 hours under aerobic conditions in Tryptic Soy Broth (TSB) (Difco) medium at 37 ⁰C 
and 180 rpm. Erythromycin 25 μg μL-1 (Roth) was used as the selective antibiotic in the mutant 
strain (mqoI::Tn).  
S. aureus growths were performed in a complex and rich medium, TSB, containing 14 
mM glucose (Table 7.1 in Supplemental Material), and also in a chemically defined medium 
(CDM) (Table 7.2 in Supplemental Material) prepared according to Nicholas P. Vitko and Anthony 
R. Richardson43. 
 Since CDM is a controlled medium, it is possible to vary the growth conditions, thus the 
carbon sources were varied according to the different experiments: 5 mM glucose (D-Glucose 
anhydrous, extra pure; Scharlau); 5 mM acetate (sodium acetate anhydrous; Panreac); or 5 mM 
lactate (Potassium L-Lactate; FLUKA). In all the different conditions, two variables were 
monitored during the growth, the optical density at 600 nm (OD600) (Shimadzu UV-3100 
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spectrophotometer) and the pH (pH meter GLP 22; Crison Instruments, SA), measured at 1-hour 
intervals.  
Cultures were grown aerobically in 250 mL Erlenmeyer flasks (VWR) (volume 1:5 of the 
flasks total capacity) in an orbital shaker (INFORS HT) at 220 rpm under 37 ⁰C, to guarantee 
aerobic conditions. Cultures were initiated by addition of the correspondent pre-culture, to an 
initial optical density at 600 nm (OD600) of about 0.13-0.15, in TSB medium, or about 0.04-0.05 
for CDM medium.  
For metabolite NMR (nuclear magnetic resonance) analyses, S. aureus growths 
(triplicates) were used. Samples were collected at different time-points during the growth. Culture 
cells were grown in the same conditions (volume 1:5 of the flasks total capacity) in 500 mL 
Erlenmeyer flasks (VWR). OD600 and pH values were measured every 2 h for TSB medium, and 
at 1.5 h for CDM medium. Samples (1.5 mL) were collected by centrifugation (13,000 rpm, 5 min, 
4 ⁰C) (Micro Star 17R; VWR) and the supernatant solutions were stored at -20 ⁰C. 
The handling of S. aureus was always performed inside a laminar flow chamber (Class II 
Type A/B3 Laminar Flow Biological Safety Cabinet; NUAIRE).  
 
3.3.4. NMR-based Metabolomics  
3.3.4.1. Sample preparation 
Extracellular metabolome 1H-NMR analysis performed in 5 mm glass tubes (7 inch in 
length; NORELL 508-UP). For each collected sample, 400 µL were used and buffered to pH 7.0 
by adding 200 µL 200 mM sodium hydrogen phosphate buffer (Panreac) solution, prepared with 
100 % D2O (deuterium oxide) (CortecNet), to provide a nuclear magnetic resonance (NMR)-lock 
signal. Additionally, the buffer solution contained a final concentration of 1 mM of TSP (3-
trimethylsilyl-[2,2,3,3-D4]-1-propionic acid) (Uvasol®) as an internal standard for subsequent 
quantification, used for chemical shift referencing and normalization of NMR peak intensities. 
3.3.4.2. NMR data collection 
All 1H-NMR spectra were obtained at 25 ⁰C on a Bruker AVANCE III 500 NMR 
spectrometer, operating at a central frequency of 500.13 MHz (Bruker Biospin, Rheinstetten, 
Germany), equipped with a 5 mm TCI C/N Prodigy Cryo probe. The equipment was controlled via 
Topspin version 3.2 software (Bruker Biospin, Rheinstetten, Germany). Spectra were acquired 
with water presaturation during a delay of 2 s and using a total recycling time of 35 s to allow full 
relaxation of the signals. Two hundred forty-three spectra were collected. 16 transients were 
collected into 64k data points using a spectral width of 16 ppm. Fourier transform was performed 
with no exponential multiplication. The NMR data was acquired at CERMAX, ITQB-NOVA, Oeiras, 
Portugal. 
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3.3.4.3. NMR data analyses and quantification 
1H-NMR spectra analyses were performed using Topspin version 3.2 software (Bruker 
Biospin, Rheinstetten, Germany). Spectra were automatically phased and baseline-corrected, 
and the chemical shift scale was set by assigning the value of δ=0.00 ppm to the signal from the 
added TSP. Compound identification was done by matching the obtained spectra with a 1H-NMR 
spectra databank using Chenomx Nmr Suite Version 8.12 software (Chenomx Inc.) and 
comparing with spectra of standard compounds.  
Quantification was done by integration of designated peaks, considering the number of 
protons responsible for each signal in the defined frequencies (Table 7.3 in Supplemental 
Material), and comparing with the added standard TSP (integral calibrated as 9 protons, 
considering the number of protons and the concentration in which it was present, 1 mM). The 
molar concentration of each compound was estimated also considering the sample dilution (3:2). 
For each triplicate assay, the median was calculated and the standard deviations were 
determined, for all the metabolic peaks studied. 
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4. Results and Discussion  
4.1. Malate:quinone oxidoreductase I   
4.1.1. Protein expression and purification 
Malate:quinone oxidoreductases from S. aureus have been overlooked and were never 
purified. In order to study and biochemically characterize these proteins, purification experiments 
were initiated.  
Ten purification trials were performed to obtain MQO I, changing different conditions, 
including type of expression cells, growth medium, IPTG concentration for gene expression, 
centrifugation times for harvesting cells, buffer solutions, extraction methods for protein removal 
from the membranes, chromatographic procedures (different columns and/or gradients), among 
others. Taking into account all attempts and optimization steps, the two most promising 
purification processes of MQO I will be described below. 
 
4.1.1.1. First purification trial 
Expression tests had been already performed at the beginning of this thesis project, thus 
we started with the best achieved methodology. In the first purification trial, E. coli C43 cells were 
used, because these cells usually provide high growth levels and are recommended for 
membrane protein expression44. Transformed E. coli cells with the plasmid containing the gene 
coding for MQO I, grew overnight in LB medium with 50 µg mL-1 kanamycin at 25 ⁰C and 180 rpm. 
Gene expression was induced with 0.5 mM IPTG at cell density correspondent to OD600 of 0.6. A 
SDS-PAGE confirming the expression of the enzyme is shown below in Figure 4.1. 
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Figure 4. 1 - SDS-PAGE of cells expressing MQO I. SDS-PAGE: Stacking Gel – 4 % acrylamide; Resolving 
Gel – 15 % acrylamide; Lane 1 – E. coli C43 cell extract before IPTG addition (OD600 = 0.6); Lane 2 – E. 
coli C43 cell extract after overnight (16 h) induction. Theoretical molecular mass of MQO I: ~ 57 kDa. Low 
molecular weight (LMW) protein marker was used (M). 
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 The gel shows in lane 2 (cells after induction) the presence of a band between the 45 and 
66 kDa markers that is not observed in lane 1 (cells before induction), indicating the expression 
of the protein. Based on the obtained results, large cell growths were performed in the same 
conditions, in order to obtain sufficient cell mass as starting material to purify the protein of 
interest. The growth yield was approximately 5 g L-1. Cells were harvested after overnight growth 
and stored at -20 ⁰C until further use. 
Approximately 100 g of thawed cells were suspended in 20 mM Tris-HCl buffer pH 7.8, 
10 % glycerol, 250 mM NaCl, before being disrupted using a French Press at 41.4 MPa. Disrupted 
cells were separated from non-disrupted ones by centrifugation at 10,000 rpm for 10 min, and the 
membrane fraction (containing the protein) was separated from the soluble fraction by 
ultracentrifugation at 42,000 rpm, 4 h. This duration was not sufficient to separate both fractions, 
and a new ultracentrifugation was performed for 14 h (overnight). The obtained membrane pellet 
was resuspended in 20 mM Tris-HCl buffer pH 7.8, 10 % glycerol, 500 mM NaCl, 0.1 % EDTA, 
with a Potter homogenizer. EDTA was added to the buffer to increase protein stability.  
Removal of protein from the membrane was achieved by solubilizing the membranes with 
the detergent n-dodecyl-β-D-maltoside (DDM). The process of solubilisation of membrane 
proteins depends on the amount of detergent relative to membrane protein. Thus, the amount of 
detergent added was proportional to the amount of protein, which was measured by the Biuret 
Protein Assay.  
In this protein quantification method, samples are combined with Biuret Reagent which 
contains copper ions in a basic solution. When an amino group and a carboxyl group join to form 
a peptide bond, the amino group (-NH2) becomes an amide group (-NH). In a basic pH, copper 
ions will complex with the amide groups of the proteins, providing a characteristic blue colour that 
is measured using absorbance spectroscopy. The quantity of protein is directly proportional to the 
intensity of the blue colour45.  
 A calibration curve was constructed according to the protocol39 (Figure 4.2), varying the 
standard protein concentration. The absorbance of the sample of interest was also measured and 
y = 0.281x + 0.0134
R² = 0.9957
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Figure 4. 2 - Calibration curve (dotted line) was calculated by a linear regression equation. The absorbance 
was measured at 540 nm. The error bars are relative to triplicate assays. 
25 
 
the amount of protein determined was about 2.82 g L-1, calculated based on the regression 
equation. Three grams of detergent were used per gram of protein, thus 8.4 g of DDM were 
gradually added to the membrane fraction and incubated overnight at 4 ⁰C, under agitation. 
 Detergents play an essential role in the solubilisation, purification, and manipulation of 
membrane proteins; their amphiphilic structure (both hydrophobic and hydrophilic) allows the 
interaction with hydrophobic membrane proteins to keep them water-soluble outside of their 
native bilayer environment. Detergent binds to the membrane, and solubilisation occurs in the 
form of a detergent-lipid-protein complex. Furthermore, the solubilisation of this complex provides 
detergent-protein complexes and detergent-lipid complexes46. MQO I has been described as a 
monotopic enzyme, like other quinone reductases, but since these proteins have not been yet 
properly characterized, their interactions with the membranes are not known4,17,47.  
 The solubilized membrane fraction gained a “yellowish” hue, suggesting a successful 
solubilisation of MQO I. Soluble and membrane fractions were separated again by 
ultracentrifugation at 42,000 rpm, 3 h. The ionic strength of the resulting supernatant (solubilized 
fraction) containing MQO I, was decreased stepwise in an Amicon concentrator/Diaflo from 500 
mM to 50 mM NaCl in order to allow an ionic exchange chromatography step.  
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Figure 4. 3 - A) UV-Visible absorption spectrum of the solubilized membrane fraction. B) Malate:quinone 
oxidoreductase activity of the solubilized membrane fraction, using 15 mM L-malic acid and 150 µM DMN. 
The wavelength was monitored at 270 nm, 30 ⁰C. C) Enzyme activity of the solubilized membrane fraction, 
using 15 mM L-malic acid and 100 µM DCPIP, as electron acceptor. This activity was monitored at 600 nm, 
30 ⁰C.  
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 The solubilized fraction was evaluated by UV-Visible absorption spectroscopy and 
enzymatic activity, with both DMN or DCPIP as electron acceptors, in order to confirm the 
presence of malate:quinone oxidoreductase I (Figure 4.3).  
 Figure 4.3 (A) shows a band with absorbance at 450 nm characteristic of a flavoprotein20, 
although absorbance attributed to some contaminants is also observable, especially at 410 nm, 
probably due to the presence of a cytochrome contamination. Cytochromes are proteins with 
characteristic strong absorption of visible light. Absorption spectrum of cytochrome c reveal a 
typical absorption peak at 410 nm in the oxidized state, while in the reduced form it presents three 
characteristic α, β and γ absorption bands, approximately absorbing at 550, 520 and 420 nm, 
respectively2,48,49 – Figure 7.2 in Supplemental Material. Despite being a soluble protein, 
cytochrome c, associates with the membrane through electrostatic interactions2.  
 Malate:quinone oxidoreductase activity was followed by absorption spectroscopy, at 270 
nm evaluating the redox state of the quinone (DMN). Malate (L-malic acid) was used as electron 
donor and DMN as electron acceptor. The enzymatic activity was also tested using the DCPIP as 
electron acceptor (600 nm). DCPIP is an artificial electron acceptor, often used to detect MQO 
activity in membranes and it has the advantage of absorbing at 600 nm with a high extinction 
coefficient14,17. In the respective monitored wavelengths, the absorbance should decrease for the 
two electron acceptors. These are being reduced and their respective reduced state does not 
present change at the chosen wavelengths. These enzymatic assays were performed to confirm 
the success of the protein solubilisation and by consequence to confirm the presence of MQO I 
in our sample.  
  
 The solubilized fraction was injected in a Q-Sepharose HP column 74 mL and eluted with 
a NaCl gradient ranging from 0 to 1 M. This strong anion exchange chromatography column 
promotes the binding of the proteins of interest to the separation medium at low ionic strength, 
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Figure 4. 4 - Chromatogram obtained in the purification of MQO I from S. aureus, by a Q-Sepharose HP 
column 74 mL. Flux = 3 mL/min. In black filled line is represented the absorbance at 280 nm, in dashed line 
is represented the % of 1 M NaCl, 20 mM Tris-HCl buffer pH 7.8, 10 % glycerol (buffer B). The protein eluted 
approximately at 30 % of B (blue). 
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which are then eluted with a salt gradient. The resulting chromatogram is shown in Figure 4.4. 
Fractions containing MQO I were identified by UV-Visible spectroscopy and by enzymatic assays. 
The protein eluted at around 30 % buffer B, corresponding to 300 mM NaCl, as shown in Figure 
4.4. 
 Since the fraction of interest still presented some contaminants, observed in the UV-
Visible absorption spectrum, another injection in Q-Sepharose HP column was performed in the 
same conditions. The chromatogram revealed a similar pattern, with the protein eluting equally at 
300 mM NaCl. Fractions containing MQO I were concentrated and further injected in a size-
exclusion chromatography column (S200 300 mL). This type of chromatography separates the 
different compounds according to their molecular size. Separation occurs depending on the 
inclusion or exclusion of the molecules from the pores within the matrix. Small molecules diffuse 
into the pores and their flow through in the column is retarded according to their size, while large 
molecules do not enter into the pores and are consequently eluted in the column’s void volume. 
Thus, molecules are separated based on their size and are eluted in order of decreasing 
molecular mass.  
 The resulting chromatogram is shown in Figure 4.5. Fractions were selected according to 
the corresponding absorption spectra, to the ratio between the absorbance intensities at 280 nm 
and 450 nm (Abs280/Abs450), and also based on a positive result for enzymatic activities with 
malate:DCPIP oxidoreductase. DCPIP was used, instead of the quinone, due to its advantages 
namely having a higher ε, which allows higher sensitivity.  The fraction containing MQO I eluted 
at about 300 min (~ 150 mL). Three injections were done in this size exclusion column, 
considering the injection volume limit. All presented the same elution pattern.   
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Figure 4. 5 - Chromatogram obtained in the purification of MQO I from S. aureus in a S200 column 300 mL, 
with 20 mM Tris-HCl buffer pH 7.8, 10 % glycerol, 150 mM NaCl. Flux = 0.5 mL/min. In black filled line is 
represented the absorbance at 280 nm. The protein eluted around 150 mL (blue). 
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Since the fraction of interest was still not pure, another injection was performed, this time 
in an affinity chromatography Hi Trap IMAC HP 5 mL column charged with zinc (Zn2+) and using 
a concentration gradient of L-histidine as eluent. This chromatographic method is used for the 
purification of histidine-tagged proteins and provides high binding capacity. MQO is expressed 
with a tail of six histidines inserted and so we decided to try this procedure. The use of zinc as 
the ion chosen for Immobilized Metal ion Affinity Chromatography (IMAC) was based on several 
factors. Cobalt had already been tried and the purification was not successful, and copper, 
manganese and nickel were described as inhibitors of MQO activity at very low concentrations, 
for Bacillus sp. PS316. The resulting chromatogram is presented in Figure 4.6. 
 
Again, fractions were selected according to the corresponding absorption spectra, to the 
ratio between the absorbance intensities at 280 nm and 450 nm (Abs280/Abs450), and also based 
on enzymatic activities with malate:DCPIP oxidoreductase. The protein eluted at around 28 % B, 
corresponding to 70 mM L-histidine.  
The resulting absorption spectrum of the MQO I from S. aureus is presented in Figure 4.7 
(A), where contaminants are still noticed. However, it is possible to observe the protein expression 
in the SDS-PAGE gel, represented by an intense band in the 50-75 kDa region. During the 
different purification steps throughout the process, enzymatic activities were measured 
spectroscopically at 600 nm, using 15 mM Malate (L-malic acid) as electron donor and 0.1 mM 
DCPIP as electron acceptor. Total enzyme activity and specific activity were calculated based on 
the Beer-Lambert law and according to the molar extinction coefficient of DCPIP at 600 nm (ε600) 
equivalent to 20.7 mM-1 cm-1 – Table 4.1 50. No enzymatic activities were detected using 15 mM 
Lactate (L-lactate) as substrate. 
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Figure 4. 6 - Chromatogram obtained in the purification of MQO I from S. aureus, by Hi Trap IMAC HP column 
5 mL charged with Zn2+. Flux = 3 mL/min. In black filled line is represented the absorbance at 280 nm and in 
dashed line the % of 250 mM L-Histidines, 20 mM Tris-HCl buffer pH 7.8, 250 mM NaCl, 10 % glycerol (buffer 
B). The protein eluted approximately at 28 % of B (blue).  
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Table 4. 1 - Purification of MQO I from S. aureus. Enzymatic activities were measured at 30 ⁰C and 600 nm, 
following the change of absorbance of DCPIP by absorbance spectroscopy, using 15 mM Malate (L-malic 
acid) as electron donor and 0.1 mM DCPIP as electron acceptor. Total and specific enzymatic activities were 
calculated based on the Beer-Lambert law, following DCPIP at 600 nm using ε = 20.7 mM-1 cm-1 50. Kinetic 
assays were performed under anaerobic conditions, in an anaerobic chamber with O2 levels below 1 ppm. 
. 
  
Table 4.1 shows an increase in the specific activities along the purification steps, 
excepting in the last one, in which the MQO I activity was decreased. An increase in the specific 
enzymatic activity is observed till the size exclusion step. However, the last tentative to obtain a 
higher purified protein was not succeed, as reflected by a lower specific activity in relation to the 
previous step. 
An intense band between the 50-75 kDa region (highlighted in red on Figure 4.7 (B)) is 
observed in the SDS-PAGE gel, which probably corresponds to the protein of interest. This band 
was analysed by ITQB/IBET UniMS for protein identification by mass spectrometry analysis. The 
protein was identified by MALDI-TOF/TOF and the search was performed against a SwissProt 
protein database with taxonomic restriction to Bacteria. A positive protein identification was 
obtained. The report from the UniMS identified that protein as malate:quinone oxidoreductase I 
from S. aureus (Report number 1 in Supplemental Material).  
Steps 
Volume 
(mL) 
Protein 
(mg/mL) 
MQO I Activity 
Total (U) 
Specific 
(U/mg) 
1st Q-Sepharose 0.04 1.54 3.10 2.02 
2nd Q-Sepharose 0.02 2.98 7.86 2.64 
Size Exclusion 0.02 1.48 22.11 14.89 
Hi Trap IMAC (Zn2+) 0.02 0.84 5.67 6.75 
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Figure 4. 7 - A) UV-Visible absorption spectrum of MQO I from S. aureus partially purified. The inset expands 
the absorption spectrum in the 250–550 nm region. B) The respective SDS-PAGE with MQO I expression 
(highlighted in red) – lane 1. SDS-PAGE: Stacking Gel – 4 % acrylamide; Resolving Gel – 15 % acrylamide; 
Theoretical molecular mass of MQO I: ~ 57 kDa. Precision plus protein dual colour standard was used as 
marker (M). 
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Thus, the MQO I purification from S. aureus was achieved. Despite not being completely 
pure, considering the absorption spectrum which was not entirely characteristic of a flavoprotein 
and considering the SDS-PAGE gel, which still presented some contaminants, the purification 
process was further optimized. We verified that this procedure was too extensive, passing through 
several chromatography columns, leading to a low yield of protein. Thus, several trials were again 
performed to optimize the process. Taking into account all the different optimization trials, the 
most promising will be described below. 
  
4.1.1.2. Second purification trial 
E. coli Rosetta 2 (DE3) pLysS cells were now used as expression cells. Many possible 
E. coli strains are candidates to use as a host, all presenting advantages and disadvantages. 
Besides improving the levels of protein production, E. coli Rosetta_(DE3) strains were chosen 
considering they were already successfully used for the expression of other monotopic quinone 
reductases from S. aureus44,51,52. Expression tests were performed using these competent cells, 
which were transformed with the plasmid containing the gene coding for MQO I. The cells were 
grown in 2×YT-rich medium with 34 µg mL-1 chloramphenicol and 100 µg mL-1 kanamycin at 37 
⁰C and 180 rpm. The gene expression was induced with 1 mM IPTG at cell density corresponding 
to OD600 of 0.6 and cells were harvested after 4 h of induction. Figure 4.8 shows a SDS-PAGE 
gel with the expression test. 
 
 
The gel shows in lane 2 (cells after induction) the presence of a band between the 50-75 
kDa markers that is not observed in lane 1 (cells before induction), indicating the expression of 
the protein. Thus, large cell growths were performed in the same conditions. The growth yield 
was approximately 5 g L-1. 
  M              2        1 kDa 
100 
75 
50 
 
37 
 
25 
20 
 
15 
 
10 
Figure 4. 8 - SDS-PAGE showing MQO I expression (highlighted in red). SDS-PAGE: Stacking Gel – 4 % 
acrylamide; Resolving Gel – 15 % acrylamide; Lane 1 – E. coli Rosetta cell extract before IPTG addition 
(OD600 = 0.6); Lane 2 – E. coli Rosetta cell extract after 4 h of induction. Theoretical molecular mass of 
MQO I: ~ 57 kDa. Precision plus protein dual colour standard was used as marker (M). 
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In this second trial the buffer solutions were also changed: the phosphate buffer, 100 mM 
K2HPO4/KH2PO4 pH 7.0, 250 mM NaCl was used. The cells were disrupted using a French Press 
at 41.4 MPa. The posterior separation of the disrupted cells from the non-disrupted ones was 
achieved in the same way, through a centrifugation at 10,000 rpm, 10 min. The resulting 
suspension was ultracentrifuged at 42,000 rpm for 2 h, and not overnight as in the first trial. The 
membrane solubilized fraction containing the protein of interest was obtained by washing the 
membranes with high ionic strength, instead of using detergent, as in the previous described 
procedure. Thus, the membrane pellet was resuspended with a Potter homogenizer in 100 mM 
K2HPO4/KH2PO4 pH 7.0, 2 M NaCl and incubated overnight at 4 ⁰C under agitation. Then, the 
membrane fraction was again ultracentrifuged at 42,000 rpm for 1 h and the ionic strength of the 
resulting supernatant containing MQO I, was equally decreased stepwise in an Amicon 
concentrator/Diaflo from 2 M to 50 mM NaCl in order to further inject into an ionic exchange 
chromatography column.  
 
 
Figure 4.9 (A) represents the absorption spectrum of the washed membrane fraction, and 
Figure 4.9 (B) shows the comparison between the spectra of the membrane fraction solubilized 
with detergent (black dashed line) and the membrane fraction obtained by washing with high ionic 
strength (black filled line), respectively described in the first and in the second trials.  
In this second trial, the cytochrome contamination is less intense when cells were 
harvested 4 h after induction of gene expression and when the protein is removed from the 
membranes with 2 M NaCl (Figure 4.9). Host laboratory experience suggests that the 
cytochrome’s expression increases during an E. coli overnight growth, which is also supported by 
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Figure 4. 9 - A) UV-Visible absorption spectrum of the membrane fraction washed with 100 mM 
K2HPO4/KH2PO4 pH 7.0, 2 M NaCl. The inset expands the absorption spectrum in the 250–550 nm region. 
B) Comparison of the absorption spectra of the membrane fractions solubilized with detergent (dashed line) 
and washed with 2 M NaCl (filled line). 
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these data. This method is advantageous when compared to the methodology described in the 
previous trial (using detergent), not only due to the elimination of contaminants, but also because 
it has no detergent related interferences for further studies, and it is important to bear in mind that 
the use of NaCl instead of detergent is more economical and environmentally friendly. These 
changes contributed positively to the optimization of the purification process.  
The fraction washed with high ionic strength, containing MQO I, was injected in a Q-
Sepharose HP column 74 mL and eluted with a NaCl gradient ranging from 0 to 1 M, similarly to 
the first described procedure. The resulting chromatogram is shown in Figure 4.10.  
 
Fractions containing MQO I were identified by UV-Visible absorption spectroscopy, based 
on the ratio between the absorbance intensities at 280 nm and 450 nm (Abs280/Abs450). Figure 
4.10 (B) presents the absorption spectrum of the selected fraction resultant from the Q-Sepharose 
HP column. Several contaminants were eliminated with this chromatography step. Similarly to the 
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Figure 4. 10 - A) Chromatogram obtained in the purification of MQO I from S. aureus, by a Q-Sepharose 
HP column 74 mL. Flux = 3 mL/min. In black filled line is represented the absorbance at 280 nm, in black 
dashed line is represented the % of 1 M NaCl, 100 mM K2HPO4/KH2PO4 pH 7.0 (buffer B). The protein 
eluted approximately at 35 % of B (blue). B) UV-Visible absorption spectrum of the selected fraction from 
the Q-Sepharose HP column (blue box in (A)) containing MQO I. The inset expands the absorption spectrum 
in the 270–570 nm region. 
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first described procedure, MQO I eluted with approximately 350 mM NaCl. These fractions were 
concentrated and further injected in a size exclusion chromatography column, using a phosphate 
buffer, 100 mM K2HPO4/KH2PO4 pH 7.0, 250 mM NaCl. The fraction containing MQO I eluted at 
about 125 min (~ 250 mL) – Figure 4.11.  
 
 
Finally, fractions containing the protein of interest were injected in an anion exchange 
Mono Q 5/50 GL column, which is a chromatography column that presents maximum resolution 
leading to high purity levels. The chromatographic principle is the same applied for the Q-
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Figure 4. 11 - Chromatogram obtained in the purification of MQO I from S. aureus by a S200 column 300 
mL, with 100 mM K2HPO4/KH2PO4 pH 7.0, 250 mM NaCl. Flux = 0.5 mL/min. In black filled line is 
represented the absorbance at 280 nm. The protein eluted around 125 mL (blue). 
Figure 4. 12 - Chromatogram obtained in the purification of MQO I from S. aureus, by a Mono Q 5/50 GL 
column. Flux = 1 mL/min. In black filled line is represented the absorbance at 280 nm, in black dashed line 
is represented the % of 1 M NaCl, 100 mM K2HPO4/KH2PO4 pH 7.0 (buffer B). The protein eluted 
approximately at 35 % of B (blue). 
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Sepharose HP column, providing the binding of the proteins of interest to the separation medium 
which are further eluted with a gradient of salt, ranging from 0 to 1 M NaCl. Fractions containing 
MQO I were selected in the same way as in the previous steps. The chromatogram is represented 
in the Figure 4.12. The protein eluted around 35 % buffer B, corresponding to 350 mM NaCl.  
The resulting absorption spectrum of the MQO I from S. aureus is presented in Figure 
4.13. In this case, the spectrum seems only to present characteristics of a flavoprotein, with its 
absorption band at 450 nm, in contrast with the final spectrum of the first described trial (Figure 
4.7 (A)), in which the cytochrome contamination was considerable.  
 
 
The SDS-PAGE gel (Figure 4.13 (B)) shows an intense band at around 50 kDa which 
probably corresponds to the protein of interest (theoretical molecular mass ~ 57 kDa). When 
compared to the final gel of the first described trial (Figure 4.7 (B)), we can observe that this gel 
presents less contaminants. However, there are still a set of thinner and less intense bands, which 
indicate that the protein is not completely pure. Enzymatic assays were performed to confirm the 
presence of malate:quinone oxidoreductase, following the quinone reduction 150 µM DMN, at 
300 nm, and using 15 mM Malate (L-malic acid) as electron donor, at 30 ⁰C. These enzymatic 
activities were also tested in the presence of an inhibitor, the 2-n-heptyl-4-hydroxyquinoline-N-
oxide (HQNO), which is a known inhibitor of many proteins of the respiratory chain that interacts 
with quinones52,53. HQNO functions as a potent quinone-site inhibitor. In order to confirm that the 
enzymatic activity measured was specific, experiments were also performed using 150 µM HQNO 
(the same proportion as the quinone). We observed that in the presence of HQNO the MQO I 
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Figure 4. 13 - A) UV-Visible absorption spectrum of MQO I from S. aureus purified. The inset expands the 
absorption spectrum in the 250–550 nm region. B) The respective SDS-PAGE with MQO I protein 
(highlighted in red) – lane 1. SDS-PAGE: Stacking Gel – 4 % acrylamide; Resolving Gel – 15 % 
acrylamide; Theoretical molecular mass of MQO I: ~ 57 kDa. Precision plus protein dual colour standard 
was used as marker (M). 
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activity was approximately 47 % decreased (Figure 4.14). No enzymatic activity was detected 
using Lactate as substrate.  
 
In summary, after ten attempts, the purification of malate:quinone oxidoreductase I from 
S. aureus was achieved. Nonetheless, this process still needs further optimization in order to 
proceed with the biochemical characterization of this promising protein.   
 
4.2. Malate:quinone oxidoreductase II 
4.2.1. Protein expression and purification 
The purification of the so assigned second copy of malate:quinone oxidoreductases 
(MQO II) from S. aureus was achieved on the first attempt. The expression conditions of MQO II 
had already been tested when this thesis project started. Under the stipulated conditions, 
transformed E. coli C43 cells with the plasmid containing the gene coding for MQO II, were grown 
in TB medium supplemented with 50 µg mL-1 kanamycin, at 37 ⁰C and 180 rpm. Gene expression 
was induced with the addition of 0.1 mM IPTG at an optical density of 0.6, at 600 nm. The 
temperature was changed to 18 ⁰C after the induction. Cells were harvested after overnight 
growth, and stored at -20 ⁰C.  
Cell growths were performed under the described conditions, in large scale, to obtain 
sufficient cell mass as starting material to purify the protein of interest. The growth yield was 
approximately 5 g L-1. Approximately 100 g of thawed cells were suspended in 100 mM 
K2HPO4/KH2PO4 buffer pH 7.0, 250 mM NaCl and disrupted in a French press at 41.4 MPa. 
0
0.05
0.1
0.15
0.2
0.25
0.3
1 2
A
c
ti
v
it
y
 (
µ
m
o
l 
m
in
-1
m
g
-1
)
Figure 4. 14 - Specific MQO I Activity. 1: Malate:quinone oxidoreductase activity; 2: MQO I activity in the 
presence of 0.15 mM HQNO. Enzymatic activities were performed under anaerobic conditions, in an 
anaerobic chamber with O2 levels below 1 ppm. Each assay was performed in triplicate at 30 ⁰C and 
following the quinone reduction (DMN) by absorption spectroscopy at 300 nm, using 15 mM Malate (L-malic 
acid) as electron donor and 0.15 mM DMN as electron acceptor, in 100 mM phosphate buffer pH 7.0, 250 
mM NaCl. HQNO was used in a proportion 1:1 to the quinone. Total enzyme activity and specific activity 
were both calculated based on the Beer-Lambert law and according to a molar extinction coefficient of DMN 
of 15.2 mM-1 cm-1 64. 
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Cellular debris and undisrupted cells were separated out by centrifugation at 10,000 rpm for 10 
min. The resulting suspension was ultracentrifuged at 42,000 rpm, 2 h. Partial membrane protein 
solubilization was achieved by washing the membranes with high ionic strength (2M NaCl). This 
was the chosen procedure since it was shown to be the most suitable for MQO I. Thus, the 
membrane pellet was resuspended with a Potter homogenizer in 100 mM K2HPO4/KH2PO4 buffer 
pH 7.0, 2 M NaCl and incubated overnight at 4 ⁰C, under agitation. No detergents were used 
during the solubilisation and purification of the enzyme. The transfer of the protein to the soluble 
fraction was confirmed by the observed colour change, to the characteristic yellowish hue of a 
flavoprotein. The membrane fraction was again ultracentrifuged at 42,000 rpm, 1 h, to isolate the 
soluble fraction containing the protein of interest. The ionic strength of the resulting soluble 
fraction (supernatant) was decreased to approximately 50 mM NaCl at 4 ⁰C by successive 
additions of 100 mM phosphate buffer pH 7.0 in order to inject it in an ionic exchange 
chromatography column, Q-Sepharose HP 74 mL.    
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Figure 4. 15 - A) Chromatogram obtained in the purification of MQO II from S. aureus, by a Q-Sepharose 
HP column 74 mL. Flux = 3 mL/min. In black filled line is represented the absorbance at 280 nm, in dashed 
line is represented the % of 1 M NaCl, 20 mM Tris-HCl buffer pH 7.8, 10 % glycerol (buffer B). The protein 
eluted approximately at 30 % of B (blue). B) UV-Visible absorption spectrum of the selected fraction from 
the Q-Sepharose HP column (blue box in (A)) containing MQO II. The inset expands the absorption 
spectrum in the 270–570 nm region. 
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The chromatogram is shown in Figure 4.15 (A). Fractions containing MQO II were 
selected according to their UV-Visible absorption spectra, considering the ratio between the 
amount of flavin per amount of protein (Abs280/Abs450).  Figure 4.15 (B) shows the absorption 
spectrum of the resulting fraction, containing MQO II, from this chromatography column. Similarly, 
to MQO I, MQO II eluted with approximately 300 mM NaCl (30 % buffer B).  
Fractions were concentrated and applied to a size exclusion chromatography column, 
using a phosphate buffer, 100 mM K2HPO4/KH2PO4 pH 7.0, 250 mM NaCl, which separated the 
different compounds according to their size. The resulting chromatogram is presented in Figure 
4.15. Again, fractions containing MQO II were identified by the respective absorption spectra, and 
selected according to their Abs280/Abs450 ratio. The protein eluted at around 260 min, 
corresponding to 130 mL elution volume and the respective spectrum is shown in Figure 4.17 (A). 
 
 
Two chromatography columns were sufficient to purify malate:quinone oxidoreductase II 
from S. aureus. The final UV-Visible absorption spectrum of MQO II is presented in Figure 4.17 
(A), and the corresponding protein band is shown in the SDS-PAGE gel in Figure 4.17 (B). The 
spectrum is characteristic of a flavoprotein, presenting a relevant absorption band with maximum 
at 450 nm 20. The SDS-PAGE gel reveals an intense band between the 45-66 kDa markers, which 
probably corresponds to MQO II (theoretical molecular mass of 56 kDa). We can also observe a 
set of less intense bands, indicating that there are vestigial amounts of contaminant proteins 
present. However, they do not seem to interfere in the studies further performed.  
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Figure 4. 16 - Chromatogram obtained in the purification of MQO II from S. aureus by a S200 column 300 
mL, with 100 mM K2HPO4/KH2PO4 pH 7.0, 250 mM NaCl. Flux = 0.5 mL/min. In black filled line is 
represented the absorbance at 280 nm. The protein eluted around 260 minutes (130 mL) (blue). 
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At the end, we obtained 13.26 mg of protein for further characterization. Protein 
concentration was determined using the BCA protein assay reagent, according to the respective 
kit protocol38.  
 
4.2.2. Protein identification  
The intense band present in the gel (Figure 4.17 (B)) (highlighted in red) was analysed 
by the ITQB/IBET UniMS, for protein identification. Similarly to MQO I, the protein was identified 
by MALDI-TOF/TOF and the search was performed against a SwissProt protein database with 
taxonomic restriction to Bacteria. A positive protein identification was obtained. The report from 
the Mass Spectrometry Unit determined that the protein was a Dihydrolipoyl dehydrogenase 
(DLD) from Escherichia coli (Report number 2 in Supplemental Material). This protein (EC 1.8.1.4) 
is a soluble enzyme that oxidizes dihydrolipoamide to lipoamid, and also presents a FAD cofactor, 
with a molecular mass of approximately 51 kDa 54. Thus, this band should be very close to the 
protein band relative to MQO II from S. aureus, which has a theoretical molecular mass of ~ 56 
kDa. With this small difference between their molecular weights, it is difficult to separate both 
proteins in the SDS-PAGE gel, which also has an error associated. It is possible to conclude that 
MQO II is not completely pure. Bands are overlapping or other possibilities are an inefficient 
removal of the protein from the gel and/or the DLD protein ionized and MQO II did not. Data was 
acquired using a 4800plus MALDI-TOF/TOF mass spectrometer, and the twenty-five most 
intense precursor ions from the MS spectra were selected for MS/MS analysis.  
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Figure 4. 17 - A) UV-Visible absorption spectrum of MQO II from S. aureus purified. The inset expands the 
absorption spectrum in the 250–550 nm region. B) The respective SDS-PAGE with the MQO II protein 
(highlighted in red) – lane 1. SDS-PAGE: Stacking Gel – 4 % acrylamide; Resolving Gel – 15 % acrylamide. 
Theoretical molecular mass of MQO II: ~ 56 kDa. Low molecular weight (LMW) protein marker was used 
(M). 
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4.2.3. Absorption spectroscopy 
Absorption spectroscopy was used to characterize the reduction state of the protein. 
Under anaerobic conditions, in an anaerobe chamber with O2 levels below 1 ppm, reduction of 
4.6 µM MQO II was achieved using a universal reducing agent, sodium dithionite (Na2S2O4) 
(Figure 4.18). Oxidized flavin presents maximum absorption at 450 nm 55. When the reduced 
protein was exposed to air, the spectrum immediately reassumed an oxidized pattern. These data 
show the protein is redox active. 
 
 
 
4.2.4. Enzymatic studies and substrate affinity 
A fraction containing 1.18 mg mL-1 was used for enzymatic activity tests in order to confirm 
the presence of the MQO II, using both Malate (L-malic acid) and Lactate (L-lactate) as electron 
donors, also to study the substrate specificity. Triplicate assays were performed under anaerobic 
conditions at 30 ⁰C, following DCPIP, the acceptor, at 600 nm. In Figure 4.19 are represented the 
obtained results. Total enzyme activity and specific activity were both calculated based on the 
Beer-Lambert law and according to a molar extinction coefficient of DCPIP at 600 nm (ε600) of 
20.7 mM-1 cm-1 50. It is clear that MQO II presented affinity for L-lactate and did not react readily 
with Malate, contrary to what is observed for MQO I. These results are in agreement with some 
publications which suggest to rename of this protein to lactate:quinone oxidoreductase (LQO)34,35. 
These results demonstrate that MQO I and MQO II catalyse different reactions. 
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Figure 4. 18 - Absorption spectrum of MQO II from S. aureus oxidized (black filled line) and reduced (black 
dashed line) with sodium dithionite, in 100 mM phosphate buffer pH 7.0, 250 mM NaCl. Spectra were 
acquired under anaerobic conditions, on a spectrophotometer placed inside an anaerobe chamber with O2 
levels below 1 ppm. The inset expands the absorption spectrum in the 250–650 nm region. 
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4.2.5. Enzymatic activity pH profile 
Enzymatic activities were tested at different pH values, with the aim of determining the 
pH at which MQO II presents the highest activity. Experiments were performed in triplicate, under 
anaerobic conditions, at 30 ⁰C and following the change in absorbance of DCPIP at 600 nm. 0.1 
mM DCPIP was used as electron acceptor and 15 mM Lactate (L-lactate) used as electron donor. 
pH values between pH 5.5 and pH 8, were provided by 50 mM MES, 50 mM Bis-Tris Propane, 
250 mM NaCl buffer, by changing the buffer pH. The protein concentration used was 
approximately 0.92 µM. The results are shown in Figure 4.20. 
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Figure 4. 19 - Specific MQO II activity. Enzymatic activities were performed under anaerobic conditions, in 
an anaerobic chamber with O2 levels below 1 ppm. Each assay was performed in triplicates at 30 ⁰C and 
following the DCPIP spectroscopically at 600 nm, using 15 mM Malate (L-malic acid) or 15 mM Lactate (L-
lactate) as electron donors and 0.1 mM DCPIP as electron acceptor, in 100 mM phosphate buffer pH 7.0, 
250 mM NaCl. Total enzyme activity and specific activity were both calculated based on the Beer-Lambert 
law and according to a molar extinction coefficient of DCPIP at 600 nm (ε600) equivalent to 20.7 mM-1cm-1 
50.  
Figure 4. 20 - pH-dependent enzyme activity of MQO II from S. aureus. Each point is representative of three 
experiments (respective error bars), using 0.1 mM DCPIP as electron acceptor and 15 mM L-lactate as 
electron donor, and with a protein concentration of 0.92 µM MQO II. Assays were measured in an anaerobe 
chamber with O2 levels below 1 ppm, at 30 ᵒC and 600 nm, with different pH buffer solutions 50 mM MES, 
50 mM Bis Tris Propane, 250 mM NaCl buffer. Specific enzyme activity was calculated based on the Beer-
Lambert law and according to a molar extinction coefficient of DCPIP at 600 nm (ε600) equivalent to 20.7 
mM-1 cm-1 50. 
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In the stipulated conditions, the results shown in Figure 4.20 indicated that the maximal 
activity for MQO II occurs at pH 7.0, with a specific activity of approximately 12 nmol min-1 mg-1. 
At pH 5.5, the protein presents a minimal activity (~ 1.5 nmol min-1 mg-1), which consequently 
increases with the pH increase until pH 7.0.     
 
4.2.6. Protein stability analysis 
Thermal denaturation experiments were performed, aiming to study protein stability and 
contributing in this way to the biochemical and functional characterization of MQO II. Temperature 
stability was analysed by measuring the fluorescence emission intensity at two different 
wavelengths, 355 nm (excitation at 280 nm) and 530 nm (excitation at 450 nm), respectively 
corresponding to the tryptophan and to the flavin emission peaks. The protein denaturation profile 
was followed in the range 25 to 90 ⁰C, and the obtained results are presented in Figure 4.21.  
 
Figure 4.21 panel (A) shows that the denaturation pattern of MQO II has an approximate 
sigmoid behaviour, starting at lower emission intensities and increasing as the temperature 
increases. The observed increase in the fluorescence emission is assumed as an increase of the 
exposure of the cofactor (FAD), upon protein denaturation. The temperature at which 50 % of the 
protein’s population is considered denatured is mathematically represented by the inflexion point 
in the sigmoid fit, named as the Melting Temperature (MT). The MT was determined using 
OriginPro 8 software, fitting a Boltzmann function (sigmoidal curve) to the data, and it was defined 
as 46.9 ⁰C for MQO II. In Figure 4.21 panel (B) is observed the exposure of tryptophan, by the 
increased intensity at ~ 50 ⁰C, and the following protein aggregation, observed from ~ 60 ⁰C.  
Figure 4. 21 - Thermal denaturation curve of the purified MQO II from S. aureus. In black dots are 
represented: (A) the fluorescence emission intensity at 530 nm (excitation at 450 nm). In filled lines is 
represented the corresponding sigmoid fit; (B) the fluorescence emission intensity at 355 nm (excitation 280 
nm), both in function of the temperature, between 25 and 90 ºC, to 2 µM MQO II.  
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a 
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4.3. Staphylococcus aureus behaviour with Different Carbon Sources   
Nowadays, S. aureus has a large contribution to the high morbidity and mortality levels, 
due to the increased incidence of its drug resistance. Therefore it is important to increase the 
knowledge on this opportunistic pathogen, including the understanding of its energetic 
metabolism. The present work contributes to this knowledge, by exploring a membrane enzyme 
involved in the catabolism of S. aureus, namely malate:quinone oxidoreductase I. We aimed at 
understand the impact of MQO I in its metabolism.  
S. aureus growths were performed for the wild-type strain (JE2 strain was used) and for 
the mutant stain, mqoI::Tn (JE2 background), presenting a transposon in the gene coding for 
MQO I. These strains were provided by the Nebraska Transposon Mutant Library41. The insertion 
of the transposon in the gene coding for MQO I was confirmed by PCR having the PCR product 
the expected size of 1,106 bp (Figure 7.3 in Supplemental Material).    
 
 
 The growths under different conditions were evaluated by monitoring optical density, 
acquired using absorption spectroscopy at 600 nm (OD600) and pH changes, measured using a 
pH electrode. S. aureus growth was first studied in a nutrient-rich medium, Tryptic Soy Broth 
(TSB) containing 14 mM glucose and an ill-defined concentration of peptides and free amino acids 
(Table 7.2 in Supplemental Material), for 15 hours (Figure 4.22). 
 Figure 4.22 shows that S. aureus wild-type growth presented an exponential phase of ~ 
6 h (blue points). This strain reached a maximal OD of approximately 16. In Figure 4.22 it is also 
observed that the pH profile is characterized by a continuous decrease since the beginning of 
growth until ~ 6 h, which corresponded to an inflection point, since this decrease was 
Figure 4. 22 - Logarithmic representation of S. aureus JE2 growth in TSB medium (initial OD 0.15, in aerobic 
conditions). The absorbance at 600 nm and the pH values were measured at 1 h intervals. The results 
presented are representative of three independent experiments (respective error bars). Comparison of the 
growths of S. aureus wild-type (blue) and mqoI::Tn (yellow) strains by optical density (A) and pH (B).  
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subsequently followed by a pH rise. The minimum pH value was observed to be around 5.8, and 
in the end of the growth the pH value was higher than that observed in the beginning. 
On the contrary, our data show that S. aureus mqoI::Tn strain reached a maximal OD of 
approximately 9 after 5 h of growth, when the stationary phase was reached (Figure 4.22; yellow 
points). Similarly to the observed for the wild-type, the pH value decreased since the beginning 
of the growth until ~ 5 h, but then it remained constant, at approximately 5.9.  
A significant difference between the growths of the wild-type strain and the strain with a 
transposon in the gene coding for MQO I was observed. S. aureus mqoI::Tn growth reached the 
stationary phase earlier than the wild-type strain, revealing a different phenotype. A significant 
difference was also observed in the pH profile, since our data show that the initial value was not 
recovered (Figure 4.22).  
 Because TSB is a very rich medium and difficult to control, additional S. aureus growths 
were performed, in a chemically defined medium (CDM) prepared as described in Table 7.2 – 
Supplemental Material. CDM is a minimal medium, easy to control. In a first approach, S. aureus 
growths of the wild-type and mqoI::Tn strains were performed in this medium supplemented with 
5 mM glucose. The variation in absorbance at 600 nm and pH values were both followed during 
the 11 hours of growth (Figure 4.23).  
 
  
 In CDM conditions (Figure 4.23) both S. aureus strains were observed to grow less when 
compared with the respective growths in TSB medium (Figure 4.22). In CDM supplemented with 
5 mM glucose, the wild-type strain reached a maximal OD around 2, after 9 h of growth (Figure 
4.23; blue points). As observed in TSB medium, the pH profile is characterized by a decrease 
Figure 4. 23 – Logarithmic representation of S. aureus JE2 growth in CDM supplemented with 5 mM glucose 
(initial OD 0.05, in aerobic conditions). The absorbance at 600 nm and the pH values were measured at 1 
h intervals. The results presented are representative of three independent experiments (respective error 
bars). Comparison of the growths of S. aureus wild-type (blue) and mqoI::Tn (yellow) strains by optical 
density (A) and pH (B).  
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since the beginning of the growth, until a minimal pH value equivalent to 7.1 after 6 h of growth, 
and subsequent increase. However, the pH value registered in the end of the growth was lower 
than that initially measured, contrarily to the observed for the wild-type growth in TSB medium.  
 In CDM supplemented with glucose, the S. aureus mqoI::Tn strain reached the stationary 
phase after around 8 h of growth with a maximal OD value of around 2 (Figure 4.23; yellow points). 
As observed in TSB medium (Figure 4.22), the pH values decreased since the beginning of the 
growth, presenting a minimal pH value around 7.1 after 8 h of growth. A subsequent pH increase 
was not observed for S. aureus strain with a transposon in the gene coding for MQO I, in TSB 
either or in CDM with glucose.  
 The mutant strain presented a delay in the growth, compared with the wild-type strain, as 
observed in Figure 4.23 panels (A) and (B), although both reached the same final OD, contrarily 
to what was observed in TSB medium (Figure 4.22).  
 It is described in the literature that under aerobic conditions, S. aureus first metabolizes 
glucose, generating pyruvate, using the pentose phosphate and glycolytic pathways28. Under 
nutrient-rich conditions (TSB medium), in the presence of a rapidly catabolizable carbon source 
such as glucose, several bacteria repress the TCA cycle. This inhibition takes place by a 
sophisticated and complex regulatory mechanism denominated as carbon catabolite repression 
(CCR). CCR is described to allow bacteria to control their energy sources and to avoid an 
energetic overflow. In this case the genes coding for proteins that enable the use of less energetic 
carbon sources, so-called secondary carbon sources, are not expressed when glucose is 
available. The catabolite control protein A (CcpA) is the major global transcription regulator of 
CCR in Firmicutes, and thus responsible for the repression of the genes and proteins of the TCA 
cycle and also the genes involved in the consumption of amino acids, when glucose is present in 
the culture growth medium56,57,58,59.  
It this situation, even under reported aerobic conditions for other microorganisms, such 
as E. coli, glucose is oxidized to Acetyl-CoA, but this does not enter the TCA cycle. Instead, 
Acetyl-CoA is converted into acetyl-phosphate and then into acetate which is subsequently 
excreted. When needed, i.e. after the complete consumption of glucose, cells consume the 
excreted acetate as carbon and energy sources to support their growth60,61. This procedure could 
also be performed by S. aureus strains, possibly explaining the pH profile during the growths.  
The pH drops observed since the beginning of the growths (TSB and CDM) of both strains 
(wild-type and mqoI::Tn) could presumably be related with the production and excretion of acidic 
metabolites, possibly acetate, during the consumption of glucose. The subsequent pH rise, only 
observed for the wild-type growths, is in agreement with a possible uptake of acetate and normal 
operation of the TCA cycle, after glucose depletion, also allowing the use of other metabolites, 
such as amino acids present in the culture growth medium. In the case of S. aureus mqoI::Tn 
growth, the pH drop was not followed by a subsequent increase (Figures 4.22 and 4.23, yellow 
points). The minimal pH value was coincident with the reach of the stationary phase in CDM 
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supplemented with glucose (Figure 4.23), possibly corresponding to the total glucose 
consumption and thus inability of this strain to catabolize acetate. This could be justified with the 
absence of the MQO I enzyme; the presence of a transposon in the gene coding for MQO I leading 
to the impairment of the TCA cycle. As described before, S. aureus does not have MDH, the 
soluble malate dehydrogenase, which is also capable to perform the oxidation of malate to 
oxaloacetate in the TCA cycle.   
In short, the differences observed between S. aureus wild-type and mqoI::Tn strains were 
more pronounced in TSB medium. This probably occurred because TSB is a nutrient rich medium, 
containing other carbohydrates besides glucose, like sucrose, and thus influencing the results. 
Despite growing less in CDM, the minimal pH values were also higher than the minimal pH values 
registered in TSB, which can be justified considering the concentration of glucose and assuming 
the CCR model.  
Other S. aureus wild-type and mqoI::Tn growths were performed in CDM, changing the 
available carbon sources. The CDM was supplemented with 5 mM acetate and the absorbance 
(600 nm) and the pH profile were both measured during the 14 hours of growth. The results are 
shown in Figure 4.24. 
Figure 4.24 panel (A) shows that both S. aureus strains presented a long lag phase. S. 
aureus wild-type strain had a maximal OD of ~ 1.3, and reached the stationary phase after 
approximately 9 h of growth (Figure 4.24; blue points). The pH values remained constant during 
the observed lag phase, and increased after ~ 7 h of growth. Contrarily to what was observed 
when cells grew in a growth medium containing glucose, the pH did not decrease. This was an 
expected situation, since no acids are being expected to be excreted in these conditions. Acetate 
was used as sole carbon source and is presumably oxidized by the TCA cycle producing CO2.  
On the opposite, S. aureus mqoI::Tn strain did not reveal a significant growth in CDM 
supplemented with acetate, as sole carbon source (Figure 4.24; yellow points). This strain 
presented a maximal OD value of 0.4 in 14 h of growth. The measured pH remained constant 
along the growth, also revealing a significant difference when compared with the pH profile 
registered for the wild-type growth. A considerable discrepancy was observed in these conditions 
for S. aureus strains lacking MQO I. One possible explanation to the observed phenotype could 
be the need for the cells, to have a functional TCA cycle in order to metabolize acetate, which is 
not the case for S. aureus mqoI::Tn. 
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S. aureus wild-type and mqoI::Tn strains were also grown in CDM supplemented with 5 
mM lactate. The absorbance (600 nm) and the pH profile were both measured during the 11 hours 
of growth. The results are shown in Figure 4.25. 
Figure 4.25 shows that S. aureus wild-type strain presented a maximal OD value 
corresponding to ~ 2.1 and reached the stationary phase after 5 h of growth, when grown in CDM 
supplemented with lactate, as sole carbon source (blue points). The pH profile remained constant 
at 7.3 until ~ 6 h, and then increased to a final value around 7.5.  
 S. aureus mqoI::Tn cells reached a maximal OD value around 1.5 after ~ 6 h of growth. 
A small increase was observed in the pH profile after ~ 7 h of growth, as observed in Figure 4.25 
(yellow points).     
 In CDM supplemented with lactate both wild-type and mutant strains presented a similar 
growth curve behaviour, although reaching different maximum OD values (Figure 4.25 panel (A)). 
Nevertheless, S. aureus mqoI::Tn strain revealed a delayed growth when compared with the wild-
type growth. Similarly to the growths performed in CDM with acetate, the pH values were constant 
from the beginning and increased after ~ 6/7 h, probably due to the consumption of metabolites 
present in the growth medium. Once more our results show that the absence of MQO I affects S. 
aureus’ fitness.   
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Figure 4. 24 – Logarithmic representation of S. aureus JE2 growth in CDM supplemented with 5 mM acetate 
(initial OD 0.05, in aerobic conditions). The absorbance at 600 nm and the pH values were measured at 1 h 
intervals. The results presented are representative of three independent experiments (respective error bars). 
Comparison of the growths of S. aureus wild-type (blue) and mqoI::Tn (yellow) strains by optical density (A) 
and pH (B).   
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Our data allowed to perform a characterization of S. aureus JE2 wild-type growths under 
different carbon sources, illustrated in Figure 4.26. The growths differed only in the carbon 
sources used in CDM, making them comparable. Our results show that S. aureus growths are 
similar in CDM supplemented with glucose (red points) or with lactate (green points), presenting 
the same final OD values, around 2. On the opposite, when grown in CDM using acetate as sole 
carbon source (orange points), S. aureus cells grow less and more slowly, probably because the 
consumption of acetate is not energetically favourable. On the other hand, the consumption of 
glucose involves the production of NADH in glycolysis, and the consumption of lactate also 
comprises the production of NADH. In these cases, cells would obtain energy by oxidation of 
NADH by the respiratory chain, and this could be one possible explanation to justify the higher 
observed yield. 
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Figure 4. 25 - Logarithmic representation of S. aureus JE2 growth in CDM supplemented with 5 mM lactate 
(initial OD 0.05, in aerobic conditions). The absorbance at 600 nm and the pH values were measured at 1 h 
intervals. The results presented are representative of three independent experiments (respective error bars). 
Comparison of the growths of S. aureus wild-type (blue) and mqoI::Tn (yellow) strains by optical density (A) 
and pH (B).     
Figure 4. 26 – Logarithmic representation of S. aureus JE2 growth under different carbon sources (initial OD 
0.05, in aerobic conditions). The results presented are representative of three independent experiments 
(respective error bars). Comparison of S. aureus wild-type growths in CDM supplemented with 5 mM glucose 
(red), 5 mM acetate (orange) or 5 mM lactate (green), by optical density (A) and pH (B). 
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A pH decrease is only observed in CDM supplemented with glucose, possibly inferring 
the presence of an active CCR in a growth medium containing glucose. In order to further explore 
these results, all S. aureus growths of both strains were repeated in exactly the same conditions, 
in TSB medium, and in CDM supplemented with 5 mM glucose, acetate or lactate, and samples 
were collected during the growth curves, to analyse the metabolites present in the culture growth 
medium, by NMR techniques.  
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4.4. Impact of MQO I in the Energetic Metabolism of Staphylococcus 
aureus 
 
S. aureus has developed several resistance mechanisms which consequently led to the 
production of increasingly resistant strains, thus it is really important to demystify what is behind 
this particular resistance ability. With the aim of investigating the impact of MQO I in the energetic 
metabolism of S. aureus, a thorough NMR-based metabolomic analysis was performed for 
different growths of wild-type and mqoI::Tn strains with several carbon sources, as described in 
the previous section. New S. aureus growths were performed (triplicate assays), in TSB medium 
(14 mM glucose) and in CDM supplemented with 5 mM glucose, acetate or lactate, in order to 
collect the samples for NMR analyses. The respective growth curves are presented in 
Supplemental Material (Figures 7.4 - 7.7). Samples of 1.5 mL were collected every 2 h or 1.5 h, 
depending on the growths. Cells were centrifuged and discarded, the supernatant (culture growth 
medium) was stored for analysis.  
NMR spectroscopy was selected because it is a powerful analytical technique widely 
used in metabolomics. It is remarkably suitable for the qualitative and quantitative analyses of low 
molecular weight metabolites in different complex biological samples. NMR offers several 
advantages for metabolomics data acquisition, since it requires minimal sample preparation.  
A 1H-NMR spectrum comprises a collection of several peaks originated from the 
molecules present in the sample which are directly proportional to their relative amounts in 
solution. Representative 1H-NMR spectra are shown in Figure 4.27. These refer to cultures 
performed in TSB medium (panel (A)) and in CDM (panel (B)). 
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Figure 4. 27 - Representative1H-NMR spectra of samples collected from a S. aureus growth, in TSB medium 
(A) and in CDM supplemented with 5 mM glucose (B). Standard metabolite peaks are evidenced, in the 
respective frequencies. Compound identification was performed with Chenomx Nmr Suite Version 8.12 
software. 
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Compound identification was done by comparison of the obtained spectra with those of 
standard compounds available at Chenomx Nmr Suite software. The peaks highlighted in Figure 
4.27 were those selected to quantify the respective metabolites. 
Once the assignment of the compounds was performed, all the collected spectra were 
analysed using Topspin 3.2 software for quantification. Figure 4.28 shows a representative raw 
data of selected compounds, such as glucose (panel (A)), acetate (panel (B)), alanine and lactate 
(panel (C)) in the respective chemical shifts, for different growth points collected at different times. 
For each analysed compound, a bar graph was created with the respective calculated 
concentration along the growth, considering the triplicate assays (Figure 4.28).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This procedure was applied for each analysed compound, for every S. aureus growth. A 
total of two hundred forty-three spectra were collected and analysed. Figure 4.29 presents the 
variation of the concentration of all identified metabolites along the growth, in this case referring 
to the S. aureus wild-type growth in CMD supplemented with 5 mM glucose. 
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Figure 4. 28 - Example of raw data spectra showing the variation of glucose (panel (A)), acetate (panel (B)), 
alanine and lactate (panel (C)) at different times of the growth (top). Respective bar graph showing 
[glucose], [acetate], [alanine] and [lactate] for different growth points. Each bar is representative of triplicate 
assays (bottom).  
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The same was done for all growths of the both S. aureus strains, wild-type (filled bars), 
and mqoI::Tn (dashed bars), in triplicates. The results are schematized in Figures 4.30 to 4.33, 
referring to the growth of the two S. aureus strains in TSB medium, in CDM supplemented with 
glucose, in CDM supplemented with acetate, and in CDM supplemented with lactate, respectively.  
 
Figures 4.30 and 4.31 show the variation of extracellular metabolites along S. aureus 
aerobic growth with glucose as the carbon source, in TSB medium and in CDM, respectively. 
Since TSB is a nutrient-rich medium, the 1H-NMR spectra were difficult to analyse, due to the 
overlapping of several peaks associated to the presence of several nutrients, which prevented 
the quantification of all metabolites. On the opposite, the 1H-NMR spectra obtained from cells 
grown in CDM were less crowded, due to the defined conditions of the growth medium, which 
consequently allowed the quantification a higher number of extracellular metabolites, providing 
also a good assess to the amino acids catabolism. It was not possible to analyse all the amino 
acids present in the medium since we used proton NMR method, and some amino acids require 
the use of other techniques, for example the carbon NMR, to be fully assessable. 
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Figure 4. 29 - Bar Graph representing the concentration of the metabolites along the growth of S. aureus 
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Figure 4.30 shows that in a nutrient rich medium, as TSB, S. aureus wild-type catabolized 
all the glucose present in the culture growth medium after around 4 h of growth (blue filled bars). 
Data also show that during that time lactate (green filled bars) and acetate (orange filled bars) 
concentrations increased in the growth medium, being the increase of acetate more pronounced. 
In the growth medium, both lactate and acetate presented a maximum concentration of 
approximately 8.5 mM after 4 h and 25 mM after 6 h. In both cases, the concentration of these 
metabolites decreased afterwards (Figure 4.30).  Our data also show that S. aureus wild-type 
catabolized alanine (yellow bars) present in the culture medium after 10 h of growth, and that 
neither tryptophan (red filled bars) nor valine (grey filled bars) concentrations changed 
significantly.  
Similarly to S. aureus wild-type, Figure 4.30 shows that S. aureus mqoI::Tn totally 
catabolized the glucose present in TSB medium, although this strain took more time to do so (blue 
dashed bars). The lactate variation presented a similar profile to that of the wild-type. For the 
mutant strain, lactate levels presented a maximum concentration of ~ 8 mM after 4 h of growth, 
which subsequently decreased (green dashed bars). In the case of acetate, the profile was 
different from the wild-type. Acetate concentration increased significantly during S. aureus 
mqoI::Tn growth, to ~ 60 mM after 12 h of growth (orange dashed bars). Figure 4.30 also shows 
that alanine was not totally catabolized by S. aureus mutant strain after 12 h of growth (yellow 
dashed bars). Tryptophan (red dashed bars) and valine (grey dashed bars) did not change their 
respective concentrations in the culture medium during the growth.  
In CDM, both S. aureus strains revealed similar behaviours to those observed in TSB 
medium, respectively. Figure 4.31 shows that in CDM supplemented with 5 mM glucose, S. 
aureus wild-type strains catabolized all glucose present in the culture growth media after ~ 4.5 h 
of growth, observed by a decrease in glucose concentration (blue filled bars). As previously 
observed in a rich media (TSB), lactate and acetate concentrations also increased in the culture 
growth medium, up to 4.5 h of growth, presenting a maximum concentration of approximately 1 
mM for lactate (green filled bars) and 8 mM for acetate (orange filled bars). After 4.5 h a decrease 
in lactate and acetate concentrations was observed. Our data also demonstrate that alanine 
(yellow filled bars) was totally catabolized after ~ 4.5 h, and both histidine (purple filled bars) and 
aspartate (soft pink filled bars) after ~ 11 h of growth. Phenylalanine (dark blue filled bars), 
tyrosine (pink filled bars) and methionine (burgundy filled bars) concentrations remained constant 
in the growth medium. Valine levels decreased but not completely (grey filled bars). Oxaloacetic 
acid was also detected along the growth. 
Figure 4. 31 - Metabolomic analyses of S. aureus JE2 wild-type (filled bars) and mqoI::Tn (dashed bars) 
growths under aerobic conditions, monitored by 1H-NMR. In the red box is represented MQO I. S. aureus 
strains grew aerobically in CDM supplemented with 5 mM glucose, at 37 ⁰C. Samples were collected every 
1.5 h of growth, centrifuged and the supernatant was stored. Extracellular metabolite concentrations were 
measured (milimoles). The results are representative of three independent experiments. The respective 
growth curves are shown in Figure 7.5 in Supplemental Material. 
56 
 
Like observed in TSB medium, S. aureus mutant strain also completely catabolized the 
5 mM glucose present in CDM (Figure 4.31; blue dashed bars), after ~ 6 h of growth. Lactate 
levels increased in the growth medium and presented a maximum concentration around 1 mM, 
after ~ 6 h (green dashed bars). Figure 4.31 shows that this increase was followed by a decrease 
in lactate concentration. As previous observed in TSB medium, acetate concentration constantly 
increased during S. aureus mqoI::Tn growth, presenting a maximum concentration of around 12 
mM after 11 h (orange dashed bars). Figure 4.31 also shows that alanine (yellow dashed bars) 
and aspartate (soft pink dashed bars) were totally catabolized by the mutant strain. On the 
contrary, our data demonstrate that histidine (purple dashed bars) phenylalanine (dark blue 
dashed bars), tyrosine (pink dashed bars), methionine (burgundy dashed bars) and valine (grey 
dashed bars) did not vary their concentrations in the culture growth medium.  
Our observations are in agreement with those observed for S. aureus growths in TSB 
medium (Figure 4.30). Analysing the results presented in Figures 4.30 and 4.31 it is possible to 
investigate S. aureus’ energetic metabolism when glucose is used as carbon source. 
In both S. aureus strains, wild-type (filled bars) and mqoI::Tn (dashed bars), glucose was 
rapidly depleted from the culture growth media. Under aerobic conditions S. aureus is described 
to use the pentose phosphate and glycolytic pathways for the catabolism of glucose28. The two 
S. aureus JE2 strains are observed to accumulate lactate and acetate while consuming glucose, 
although the accumulation of acetate is more pronounced.  
Accumulation of lactate and acetate indicates that glucose is only partially oxidized. This 
is in agreement with the literature that describes that S. aureus possesses a complex regulatory 
mechanism, the carbon catabolite repressor (CCR), as mentioned in the previous section. CCR 
is a sophisticated mechanism that prevents the loss of energy, precluding the consumption of 
other carbon sources or amino acids, while glucose is available. In the presence of CCR, the 
genes and proteins of the TCA cycle are not expressed, and consequently this cyclic pathway is 
inhibited until glucose depletion56,57,58,59. According to these reports, when S. aureus grows in a 
medium containing glucose, pyruvate produced by glucose degradation is subsequently oxidized 
to acetate, leading to its accumulation28,29,33,30,62,63. The accumulation of both products in the 
culture growth media until glucose depletion is probably responsible for the characteristic pH drop 
previously observed in both growths curves (section 4.3, Figures 4.22 and 4.23). In this case the 
organisms would obtain energy by oxidation of NADH by the respiratory chain, and by substrate 
level phosphorylation including the production of ATP from Acetyl-CoA to acetate (see the 
schematised metabolic pathways in Figure 4.31). In both S. aureus wild-type growths, the total 
glucose consumption is observed to be coincident with the uptake from the culture growth media 
of excreted lactate and acetate (Figures 4.30 and 4.31), which indicates that lactate and acetate 
are now being catabolized. This is in agreement with the reports observing that de-repression of 
the TCA cycle occurs upon glucose depletion. Then, in the form of Acetyl-CoA, acetate is oxidized 
by the TCA cycle.  
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Until glucose depletion, both S. aureus strains presented the same behaviour, although 
with different times for glucose consumption and acetate/lactate accumulation. The differences 
between both strains are more evident in the uptake of the excreted products from the respective 
growth media. As expected, the 1H-NMR analyses of collected samples from S. aureus mqoI::Tn 
growth revealed several differences when compared with the 1H-NMR results of the wild-type 
strain. S. aureus mqoI::Tn strains grew in the presence of glucose, although, the accumulated 
acetate was not imported from the growth medium after glucose depletion after ~ 6 h (Figures 
4.30 and 4.31), as observed for the wild-type. MQO I protein is involved both in the TCA cycle 
and respiratory chain. The uptake of acetate did not occur, probably because this S. aureus strain 
has the TCA cycle compromised, indicating that a fully functioning TCA cycle is essential for 
acetate catabolism. These data agree with the CCR model, even though CCR is no longer 
inhibiting the cyclic pathway. Because the S. aureus mqoI::Tn strain does not perform acetate 
catabolism, acetate concentration constantly increased during the growth (Figures 4.30 and 4.31). 
On the contrary, in Figures 4.30 and 4.31, lactate was seen to be uptaken from the growth 
medium, after glucose depletion. Taking into account that the TCA cycle is hampered and based 
on the assigned metabolic pathways, the imported lactate seemed to be possibly converted into 
acetate, first through its conversion into pyruvate (leading to the production of NADH) which was 
then converted into acetate, via Acetyl-CoA since this reaction would be advantageous to the 
cells due to the production of ATP. The non-uptake of acetate from the culture growth medium 
observed trough these 1H-NMR results, is probably responsible for the non-recovery of the pH 
values observed in S. aureus mqoI::Tn growth curves, in the previous section (Figures 4.22 and 
4.23). On the opposite, a pH rise was observed for S. aureus wild-type growth presumably due 
to the catabolism of acetate (in both CDM and TSB) and of other carbohydrates, only present in 
TSB medium, which were uptake from the medium to the cells.  
Analysing amino acids catabolism through S. aureus growths in CDM supplemented with 
glucose (Figure 4.31) the two S. aureus strains were observed to initiate the consumption of 
alanine and aspartate, before the uptake of both lactate or acetate. According to the literature, 
the catabolism of alanine and aspartate reflects the direct production of metabolic intermediates, 
respectively, pyruvate and oxaloacetate. Both amino acids were completely consumed by both 
S. aureus strains. This observation led us to conclude that the absence of MQO I does not 
interfere with the catabolism of aspartate, despite the compromised TCA cycle.  
Our results are in agreement with data published in March 2017, also obtained with 
Nebraska Transposon mutants using the same S. aureus JE2 wild-type strain36. This recent 
publication suggests that amino acids which serve to fuel the synthesis of pyruvate (namely 
alanine), and oxaloacetate (namely aspartate) are important for initiation of growth in CDM. These 
data also report the total consumption of the amino acids involved in the generation of pyruvate 
(alanine, glycine, threonine and serine). The authors suggest the existence of a bifurcation during 
amino acid catabolism in which pyruvate is produced, proposing primarily their utilization to 
generate acetate and ATP via Acetyl-CoA, and also proposing the entry of little carbon to the TCA 
cycle via citrate synthase, until the consumption of acetate from the growth medium.  
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Furthermore, Figure 4.31 shows that histidine was only completely catabolized by S. 
aureus wild-type strain after 11 h of growth. Previously mentioned data illustrate that histidine was 
catabolized slower than glutamate, proline and arginine. We could not quantify the concentration 
of those amino acids (glutamate, proline and arginine), although we observed that the 
consumption of histidine was slow, when compared with the catabolism of alanine and aspartate. 
A direct comparison between the data obtained in this thesis and that reported on March 2017 
may not be possible, because no carbon source apart from amino acids was present in the 
medium, in the mentioned report.  
 Figure 4.31 also shows a gradual consumption, but not significant, of valine, methionine, 
tyrosine and phenylalanine, observed for both S. aureus strains. The concentration of these amino 
acids remained practically the same during the growth, suggesting that they are not used for 
catabolic purposes, in these conditions. Again, our results agree with the literature36.  
Both Figures 4.30 and 4.31 illustrate the dynamics of the metabolism of S. aureus growth 
of the wild-type strain and of a mutant strain lacking MQO I enzyme, in a growth media containing 
glucose, respectively, in TSB (a nutrient-rich medium) and in CDM. Both S. aureus strains 
respectively presented a similar profile in TSB and in CDM.  
 
 
Figure 4.32 shows the variation of extracellular metabolites along S. aureus aerobic 
growths in CDM supplemented with 5 mM acetate. Samples collected during these growths were 
analysed by 1H-NMR, aiming to study their energetic metabolism in a growth medium containing 
acetate as carbon source.   
S. aureus wild-type growth (Figure 4.32; filled bars), shows an increase on the acetate 
concentration, up to 5 h of growth (orange bars). In the beginning of the growth, acetate 
concentration was around 6 mM, although it presented a maximum concentration of 
approximately 7.5 mM in the growth medium. This concentration rise was followed by a 
subsequent decrease, suggesting the consumption of acetate only after ~ 6.5 h of growth. Our 
data also show that the concentration of lactate in the culture growth medium decreased since 
the beginning of the growth (green filled bars). No glucose was detected during the growth, which 
allowed the quantification of glycine. Glycine (salmon colour filled bars) and alanine (yellow filled 
bars) were totally catabolized up to ~ 6.5 h of growth. Aspartate (soft pink filled bars) was 
completely depleted from the growth medium up to ~ 8 h of growth, and histidine (purple filled 
bars) only after 11 h. Data also demonstrate that phenylalanine (dark blue filled bars), tyrosine 
(pink filled bars) and methionine (burgundy filled bars) concentrations remained practically 
constant in the growth medium. Valine levels decreased but not completely (grey filled bars). 
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 In the case of the S. aureus mqoI::Tn growth, acetate levels were observed to be 
constantly increasing along the growth, presenting a maximum concentration of around 8.5 mM 
after 11 h (Figure 4.32; orange dashed bars). Lactate concentration decreased during the growth 
(green dashed bars). After ~ 11 h of growth, only alanine (yellow dashed bars) and glycine 
(salmon colour dashed bars) were completely catabolized by these strains, among the quantified 
amino acids. Our data also showed that aspartate started to be consumed after ~ 8 h of growth 
(soft pink dashed bars). Histidine (purple dashed bars), phenylalanine (dark blue dashed bars), 
tyrosine (pink dashed bars), methionine (burgundy dashed bars) and valine (grey dashed bars) 
concentrations remained constant in the growth medium (Figure 4.32). Oxaloacetic acid was 
detected, although in small amounts, after 8 h of growth (brown dashed bars). Also very low levels 
of fumarate were detected after 5 h of growth.  
Analysing the results presented in Figure 4.32 it is possible to investigate S. aureus’ 
energetic metabolism when acetate is the only carbon source present in the culture growth 
medium.  
In the described S. aureus wild-type growth (filled bars), lactate was observed to be the 
first metabolite to be catabolized (Figure 4.32; green bars), despite the growth medium being 
supplemented with acetate. Based on the assigned metabolic pathways and since the uptake of 
lactate involves its conversion into pyruvate and leads to the production of NADH, the rapid 
consumption of lactate from the growth medium could be interpreted as a way to generate NADH, 
which is probably further oxidized by the respiratory chain. Figure 4.32 shows that both alanine 
and glycine were also rapidly catabolized, reflecting their direct catabolism in the production of 
pyruvate. Acetate concentration increased in the growth medium (although not significantly) while 
lactate and amino acids were imported. These results are again in agreement with recent 
published data36, previously described above, recognizing the importance of amino acids involved 
in the generation of pyruvate, such as alanine and glycine, and hypothesising their use to produce 
ATP, through the conversion of pyruvate into acetate, via Acetyl-CoA. 
 Aspartate was also completely catabolized by S. aureus wild-type strain, after ~ 8h of 
growth. This consumption also agrees with the literature, that refers the catabolism of aspartate 
as a significant amino acid used to synthesize oxaloacetate, which is described as being important 
for initiating the growth in CDM36.  
As previously observed in CDM with glucose (Figures 4.31), in CDM with acetate, 
histidine was also completely catabolized by S. aureus wild-type strain, after ~ 11 h of growth 
(Figure 4.32).  
Figure 4. 32 – Metabolomic analyses of S. aureus JE2 wild-type (filled bars) and mqoI::Tn (dashed bars) 
growths under aerobic conditions, monitored by 1H-NMR. In the red box is represented MQO I. S. aureus 
strains grew aerobically in CDM supplemented with 5 mM acetate, at 37 ⁰C. Samples were collected every 
1.5 h of growth, centrifuged and the supernatant was stored. Extracellular metabolite concentrations were 
measured (milimoles). The results are representative of three independent experiments. Please note 
missing bars relative to 6.5 h of S. aureus mqoI::Tn growth. The respective growth curves are shown in 
Figure 7.6 in Supplemental Material.  
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The 1H-NMR results relative to S. aureus mqoI::Tn strains revealed several differences 
when compared to those of S. aureus wild-type strain, in CDM supplemented with acetate (Figure 
4.32). Constant increased acetate concentrations observed in the growth medium for S. aureus 
mqoI::Tn growth, led us to conclude that these strains were not able to catabolize acetate. 
However, Figure 4.32 indicates that S. aureus mqoI::Tn strains were able to uptake lactate from 
the culture growth medium. The inability to catabolize acetate had already been observed in a 
growth medium containing glucose (Figures 4.30 and 4.31) and is presumably associated with 
the compromised TCA cycle, in the absence of MQO I, which does not interfere with the 
catabolism of lactate. As previously suggested, the uptake of lactate could be advantageous to 
these cells, based on the production of NADH, and the consequently generated pyruvate could 
be probably converted into acetate via Acetyl-CoA, to produce ATP. Alanine and glycine were 
both completely catabolized by S. aureus strains lacking MQO I protein, after approximately 10 h 
of growth. Taking into account the incomplete TCA cycle and the assigned metabolic pathways, 
the catabolism of those amino acids would be advantageous because it leads to the production 
of pyruvate, and could allow the production of ATP by Acetyl-CoA.  
Catabolism of aspartate was initiated around 8 h of growth. According to the literature, 
the catabolism of aspartate is reflected by the direct production of oxaloacetate. Figure 4.32 
shows that the consumption of aspartate is coincident with the detection of oxaloacetic acid in the 
growth medium, ~ 8 h. The compromised TCA cycle, in the absence of MQO I enzyme, may lead 
to the accumulation of oxaloacetate, justifying the appearance of oxaloacetic acid in the growth 
medium. From the analysed metabolites, no other amino acids were catabolized by S. aureus 
strains lacking MQO I in these conditions.  
A significant effect reflecting the absence of MQO I was previously observed in the 
growths in CDM supplemented with acetate, where S. aureus mqoI::Tn cells grew less when 
compared with the wild-type strain (Figure 4.24). The non-catabolism of acetate is probably 
responsible for the constant pH profile observed in our 1H-NMR results, contrarily to the pH rise 
observed in S. aureus wild-type growth (Figure 4.24). Our NMR data demonstrate that S. aureus 
cells lacking MQO I are not able to catabolize acetate, despite having the other assigned MQO 
(MQO II) present. Our results show that MQO II does not compensate for the absence of MQO I 
in S. aureus mqoI::Tn growth. Thus, these observations revealed the inability of MQO II to perform 
the same reaction as MQO I, the oxidation of malate to oxaloacetate, in agreement with our 
biochemical data (section 4.2).  
Intrigued by these 1H-NMR results, and aiming to characterize S. aureus growth under 
different carbon sources, growths were also performed in a medium containing lactate, as sole 
carbon source, and samples were collected during these growths, in order to be analysed through 
NMR-based metabolomics. 
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Figure 4.33 presents the variation of extracellular metabolites along S. aureus aerobic 
growths in CDM supplemented with lactate, as the sole carbon source.   
In these conditions, S. aureus wild-type is observed to totally catabolize the lactate 
present in the culture medium after approximately 6.5 h of growth, observed by a decrease in 
lactate concentration (Figure 4.33; green filled bars). Our data also demonstrate that both alanine 
(yellow filled bars), glycine (salmon colour filled bars) and aspartate (soft pink filled bars) were 
totally catabolized by S. aureus wild-type strain, after ~ 6.5 h of growth. Acetate concentration 
increased in the growth medium since the beginning of the growth, and reached maximum 
concentration of 4 mM, around 4.5 h of growth (orange filled bars). This concentration rise was 
subsequently followed by a decrease, which started at ~ 6.5 h of growth. Histidine was completely 
catabolized by the wild-type strain, after ~ 10 h of growth (purple filled bars). Valine concentration 
decreased, but not completely (grey filled bars). Phenylalanine (dark blue filled bars), tyrosine 
(pink filled bars) and methionine (burgundy filled bars) concentrations remained constant in the 
growth medium. Pyruvic acid was detected in the 1H-NMR spectra after ~ 2 h of growth, and 
presented a maximum concentration around 1 mM after ~ 3 h. Pyruvic acid was subsequently 
imported from the growth medium, after ~ 6 h of growth (light blue filled bars).  
The S. aureus mutant strain completely catabolized all the lactate present in the medium, 
as shown in Figure 4.33 (green dashed bars), by ~ 6.5 h of growth. Figure 4.33 shows that in S. 
aureus mqoI::Tn growth, acetate concentration constantly increased during the growth, 
presenting a maximum concentration of ~ 8 mM, around 10 h of growth (orange dashed bars). 
Our data also show that alanine (yellow dashed bars), glycine (salmon colour dashed bars) and 
aspartate (soft pink dashed bars) were totally consumed by S. aureus strains lacking MQO I, and 
that histidine (purple dashed bars) was also catabolized, but not completely until 10 h of growth. 
Our results demonstrate that phenylalanine (dark blue dashed bars), tyrosine (pink dashed bars), 
methionine (burgundy dashed bars) and valine (grey dashed bars) did not significantly vary their 
concentrations in the culture growth medium of these strains. Pyruvic acid was also detected after 
2 h of growth (light blue dashed bars). This concentration was maximum at ~ 4.5 h of growth. 
Subsequently, pyruvic acid concentration totally decreased suggesting its uptake.  
The 1H-NMR results presented in Figure 4.33 allow us to acquire a new perspective of   
the studied S. aureus strains growth, this time in a medium containing lactate as sole carbon 
source.  
Our data show that in CDM both S. aureus JE2 strains (wild-type and mqoI::Tn) 
completely catabolized lactate, although at different times of the growth. For the first time, pyruvic 
Figure 4. 33 - Metabolomic analyses of S. aureus JE2 wild-type (filled bars) and mqoI::Tn (dashed bars) 
growths under aerobic conditions, monitored by 1H-NMR. In the red box is represented MQO I. S. aureus 
strains grew aerobically in CDM supplemented with 5 mM lactate, at 37 ⁰C. Samples were collected every 
1.5 h of growth, centrifuged and the supernatant was stored. Extracellular metabolite concentrations were 
measured (milimoles). The results are representative of three independent experiments. The respective 
growth curves are shown in Figure 7.7 in Supplemental Material. 
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acid was detected in the 1H-NMR spectra of S. aureus strains, right after 2 h of growth and 
subsequently disappeared after ~ 6.5 h. As observed in Figure 4.33, pyruvic acid concentrations 
increased as lactate concentrations decreased. Based on the assigned metabolic pathways in 
the literature and looking at the metabolic scheme presented in Figure 4.33, the uptake of lactate 
from the culture growth medium is known to be converted into pyruvate and subsequently 
producing NADH2,36. The considerable concentration of lactate, probably leads to a significant 
amount of generated pyruvate, which accumulates in the cells and thus can be excreted to the 
growth medium. In the cells, generated pyruvate could enter the TCA cycle via citrate synthase, 
or could be converted into acetate via Acetyl-CoA, to produce ATP. Thus, we suggest that since 
pyruvate concentrations decreased inside the cell, S. aureus uptakes the previously excreted 
pyruvic acid from the growth medium. This could be one of the possible reasons to justify the 
detected pyruvic acid concentrations observed in both S. aureus growths under these conditions.  
As previously observed in CDM supplemented with acetate, some amino acids start being 
consumed before acetate catabolism, which was only observed around 10 h of growth for S. 
aureus wild-type strain (orange filled bars). Figure 4.33 shows that alanine and glycine were 
completely catabolized after ~ 6.5 h of growth, for S. aureus wild-type strain. Recent publications 
reported that when S. aureus JE2 cells grow in the presence of amino acids that generate 
pyruvate, namely serine, threonine, alanine and glycine, these are primarily catabolized to acetate 
to fuel ATP synthesis, and that acetate only enters the TCA cycle after the depletion serine, 
threonine and alanine36. Our results show that acetate is only catabolized after alanine and glycine 
depletion, which in agreement with the literature.   
However, Figure 4.33 shows that in S. aureus mqoI::Tn growth, acetate concentration did 
not decrease in the growth medium, contrarily to the decreased acetate concentration observed 
for the wild-type strain (orange bars). As expected, the catabolism of acetate did not occur in S. 
aureus strains due to the lack of MQO I, justifying the lowest growth of these strains when 
compared with the wild-type, and a not so pronounced rise in the pH profile (Figure 4.25). Once 
more, the inability of MQO II to compensate for the absence of MQO I in S. aureus mqoI::Tn 
growth is shown. Taking into account these observations and published data suggesting MQO II 
as a putative lactate:quinone oxidoreductase34,35, and also regarding our biochemical 
characterization results of this enzyme, it is possible to conclude that MQO II catalyses a different 
reaction from MQO I.   
65 
 
5. Conclusion 
S. aureus is an opportunistic pathogen and has become a worldwide problem in clinical 
medicine due to the increased incidence of its drug resistance. For this reason, it is fundamental 
to explore and understand not only the mechanism behind this strong resistance, but also the 
basic conditions that allow S. aureus to live and survive. We aimed to contribute to this knowledge 
by exploring respiratory enzymes involved in the catabolism of S. aureus, specifically 
malate:quinone oxidoreductases.   
 We investigated the two proteins, annotated as malate:quinone oxidoreductases, MQO I 
and MQO II, from this pathogen. Protein biochemical characterization and a thorough cellular 
investigation were performed. After several purification trials and intense search for the best 
conditions, the two proteins were expressed and purified for the first time. Purified MQO I was 
identified through mass spectrometry analysis, and a preliminarily biochemical characterization 
carried out. For MQO II, the amount of protein obtained allowed spectroscopic characterization, 
protein stability tests and enzymatic analyses including substrate affinity and pH profile. Both 
proteins presented the characteristic flavin UV-Visible spectrum. MQO II was shown to be redox 
active. Enzymatic studies showed that MQO II exhibits affinity for L-lactate instead of malate, and 
that its activity is maximal at pH 7.0. Thermal denaturation experiments indicated that this 
flavoprotein is stable up to approximately 47 ⁰C.  
 Our approach was extended to the cellular level in order to understand the impact of the 
role of MQO I in the metabolism of S. aureus. These studies involved cell growth of a wild-type 
strain and also of one mutant strain, presenting a transposon in the gene coding for MQO I.   
A total of seventy-two S. aureus growths were performed and three hundred and fifteen 
samples were collected along the growths, from which two hundred forty-three were analysed 
through NMR-based metabolomics. For the first time, S. aureus growth was characterized under 
different carbon sources, glucose, acetate and lactate, in a chemically defined medium and also 
under nutrient rich conditions (TSB). The growths of the two strains were monitored by optical 
density and pH, and the respective metabolites were analysed by 1H-NMR. This allowed us to 
investigate the energetic metabolism of S. aureus and also to explore the role of MQO I in the 
different metabolic pathways.  
 When grown in TSB medium S. aureus first catabolized all glucose present in the growth 
medium, excreting lactate and acetate, which were later imported back to the cell after glucose 
depletion, elucidating the de-repression of the TCA cycle. Our results are in agreement with the 
carbon catabolite repressor mechanism described in the literature. In CDM supplemented with 
glucose, S. aureus growths presented the same behaviour, but in addition it was possible to fully 
assess amino acid catabolism. Our results obtained from the growth using different carbon 
sources showed that S. aureus preferably catabolizes glucose, then lactate and some amino 
acids, such as alanine and glycine (whose catabolism is involved in the generation of pyruvate) 
before using acetate. Our observations are in agreement with previous reports that announced 
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the initial catabolism of amino acids, directly involved in the generation of pyruvate, to further fuel 
ATP synthesis, concluding that this pathogen catabolizes amino acids to obtain energy.  
 S. aureus mqoI::Tn growths showed the importance of MQO I in this microorganism. The 
inability of this strain to catabolize acetate was observed, demonstrating that a fully functioning 
TCA cycle is necessary for acetate catabolism. The inability of the protein MQO II to compensate 
for the absence of MQO I in S. aureus mqoI::Tn growths was observed. Our experiments showed 
that these proteins do not catalyse the same reaction.  
 We conclude that MQO II is not a malate:quinone oxidoreductase, as already suggested 
in the literature. This observation is confirmed through enzymatic assays, substrate affinity studies 
and is also reinforced through extracellular metabolites of S. aureus growths of strains lacking 
MQO I (under different growth conditions), quantified by NMR-based metabolomics.  
 Our data show the importance of MQO I in the energetic metabolism of this 
microorganism. S. aureus growths were affected and compromised, in the absence of MQO I, 
making this enzyme an attractive candidate for targeted therapeutics.  
The work here presented on the study of malate:quinone oxidoreductases from S. aureus, 
opens new perspectives for future studies of these proteins. A better optimization of the 
purification processes is still needed, to develop a thorough biochemical characterization of both 
MQO I and MQO II. Both molecular and cellular approaches are fundamental to proceed with the 
study of these proteins and to contribute to the knowledge of S. aureus’ respiratory enzymes. S. 
aureus growths can be tested under different growth conditions, limiting, for example, the amino 
acids provided in the growth medium. Exploring not only the role of these proteins, but also the 
spatial/temporal localization and regulation of MQO I and MQO II in the cell membrane, should 
be an interesting future work to find the answers to understand this strong and artistic mechanism 
behind the energetic metabolism of S. aureus.  
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7. Supplemental Material  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7. 1 - Composition of TSB medium (pH 7.3 ± 0.2) (Difco) used for Staphylococcus aureus growths. 
The medium was prepared in bi-distilled water (Millipore E-POD) sterile. 
 
Solution Item Concentration Sterilize 
TSB medium 
Tryptone (Pancreatic Digest of Casein) 17 g L-1 
Autoclave  
Dipotassium Hydrogen Phosphate (K2HPO4) 2.5 g L-1 
Glucose (Dextrose) 2.5 g L-1 
Sodium Chloride (NaCl) 5 g L-1 
Soytone (Peptic Digest of Soybean Meal) 3 g L-1 
Figure 7. 2 – Absorption spectra of cytochrome c in its oxidized (dashed line) and reduced (solid line) form. 
Adapted from Matsuno et al, 200949. 
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Figure 7. 1 - Flavin UV-Visible absorption spectrum. 
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Table 7. 2 – Composition of CDM for Staphylococcus aureus growths. Salt solution, vitamin solution and 
trace elements solution were performed, the amino acids and bases were made separately to maximize the 
longevity of storage. All the solutions were stored at 4 ⁰C. Per each 100 mL of CDM medium prepared, were 
added 10 mL of the salt solution, 1 mL of each amino acid, 1 mL of each base, 0.1 mL of the vitamin solution 
and 0.1 mL of the trace elements solution. The medium was prepared in bi-distilled water (Millipore E-POD) 
sterile and the pH adjusted to 7.4 using sterile 10 M NaOH solution. 
Solution Item Concentration Sterilize 
Salt Solution 
K2HPO4 70 g L-1 
Autoclave 
KH2PO4 20 g L-1 
(NH4)2SO4 10 g L-1 
MgSO4·7H2O 0.1 g L-1 
Amino Acids 
Phenylalanine 0.004 g mL-1 Filter Sterilize 
Isoleucine 0.003 g mL-1 Filter Sterilize 
Tyrosine 0.005 g mL-1 Filter Sterilize 
Cystine 0.002 g mL-1 Filter Sterilize 
Glutamine 0.01 g mL-1 Filter Sterilize 
Lysine 0.001 g mL-1 Filter Sterilize 
Methionine 0.007 g mL-1 Filter Sterilize 
Histidine 0.003 g mL-1 Filter Sterilize 
Tryptophan 0.001 g mL-1 Filter Sterilize 
Leucine 0.009 g mL-1 Filter Sterilize 
Aspartic-acid 0.009 g mL-1 Filter Sterilize 
Arginine 0.007 g mL-1 Filter Sterilize 
Serine 0.003 g mL-1 Filter Sterilize 
Alanine 0.006 g mL-1 Filter Sterilize 
Threonine 0.003 g mL-1 Filter Sterilize 
Glycine 0.005 g mL-1 Filter Sterilize 
Valine 0.008 g mL-1 Filter Sterilize 
Proline 0.001 g mL-1 Filter Sterilize 
Bases 
Adenine 0.0005 g mL-1 Filter Sterilize 
Cytosine 0.0005 g mL-1 Filter Sterilize 
Guanine 0.0005 g mL-1 Filter Sterilize 
Thymine 0.002 g mL-1 Filter Sterilize 
Uracil 0.0005 g mL-1 Filter Sterilize 
Vitamin Solution 
Thiamine 0.001 g mL-1 
Filter Sterilize 
Niacin 0.0012 g mL-1 
Biotin 5E-06 g mL-1 
Calcium 
Pantothenate 
2.5E-04 g mL-1 
Trace Elements 
FeCl3 0.008 g mL-1 
Filter Sterilize 
ZnCl 6.95E-05 g mL-1 
MnCl·4H2O 9.9E-05 g mL-1 
Boric Acid 6E-06 g mL-1 
CoCl2·6H2O 3.97E-04 g mL-1 
CuCl2·2H2O 2.56E-06 g mL-1 
NiCl2·6H2O 2.38E-05 g mL-1 
Na2MoO4.·2H2O 3.58E-05 g mL-1 
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Table 7. 3 – Compounds analysed by 1H-NMR in the respective analysed peaks (approximated chemical 
shifts) and the number of protons responsible for each signal in the defined ppm. Assignment performed 
based on the Chenomx Nmr Suite software and on the Biological Magnetic Resonance Data Bank. 
 
 
 
Compound ~ Chemical Shift (ppm) Number of protons 
Acetate 1.9 3 
Adenine 8.2 1 
Alanine 1.47 3 
Aspartate 2.78 1 
Fumarate 6.51 2 
Glycine 3.55 2 
α - Glucose 5.23 
1 
β - Glucose 4.64 
Histidine 7.9 1 
Lactate 1.31 3 
Methionine 2.12 3 
Oxaloacetic acid 2.39 2 
Phenylalanine 7.3 1 
Pyruvic acid 2.36 3 
Tyrosine 7.2 2 
Valine 3.6 1 
1,000 
 
500 
 M     1      
bp 
10,000 
3,000 
Figure 7. 3 - 1 % Agarose gel of the confirmation of mutation mqoI::Tn. Lane 1 - PCR product (1,106 bp). 
GeneRuler DNA Ladder Mix (Fermentas) was used (M). 
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Figure 7. 4 – Logarithmic representation of S. aureus JE2 growth (wild-type and mqoI::Tn strains) in TSB 
medium (initial OD 0.15, in aerobic conditions). The absorbance at 600 nm and the pH values were 
measured and samples were collected every 2 h of growth. The results presented are representative of 
three independent experiments (respective error bars). 
Figure 7. 5 – Logarithmic representation of S. aureus JE2 growth (wild-type and mqoI::Tn strains) in CDM 
supplemented with 5 mM glucose (initial OD 0.05, in aerobic conditions). The absorbance at 600 nm and 
the pH values were measured and samples were collected every 1.5 h of growth. The results presented are 
representative of three independent experiments (respective error bars). 
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Figure 7. 6 – Logarithmic representation of S. aureus JE2 growth (wild-type and mqoI::Tn strains) in CDM 
supplemented with 5 mM acetate (initial OD 0.05, in aerobic conditions). The absorbance at 600 nm and 
the pH values were measured and samples were collected every 1.5 h of growth (excepting the first point 
of the growth). The results presented are representative of three independent experiments (respective error 
bars). 
Figure 7. 7 – Logarithmic representation of S. aureus JE2 growth (wild-type and mqoI::Tn strains) in CDM 
supplemented with 5 mM lactate (initial OD 0.05, in aerobic conditions). The absorbance at 600 nm and the 
pH values were measured and samples were collected every 1.5 h of growth. The results presented are 
representative of three independent experiments (respective error bars). 
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Report number 1 
Protein sequence coverage:  
  
Sample AS_1  
  
MASCOT SEARCH RESULTS  
  
PROTEIN VIEW 
 
Match to: sp|Q6G6V5|MQO1_STAAS Score: 754 Expect: 1.3e-070  
Probable malate:quinone oxidoreductase 1 OS=Staphylococcus aureus 
(strain MSSA476) GN=mqo1 PE=3 SV=2  
  
Nominal mass (Mr): 54751; Calculated pI value: 6.26  
  
Variable modifications: Carbamidomethyl (C),Deamidated (NQ),Gln-
>pyro-Glu  
(N-term Q),Oxidation (M)  
Cleavage by Trypsin: cuts C-term side of KR unless next residue is P 
Sequence Coverage: 54%  
  
Matched peptides shown in Bold Red  
  
     1 MTTQHSKTDV ILIGGGIMSA TLGTLLKELS PEKNIKVFEK LAQPGEESSN   
    51 VWNNAGTGHS ALCELNYTKE GKDGTVDCSK AIKINEQYQI SKQFWAYLVK   
   101 TGQLDNPDRF IQAVPHMSFV IGEDNVAFIK SRVATLKKSV LFEKMKLSQD   
   151 EEEMKSWVPL MIEGRKSDEP IALTYDETGT DVNFGALTAK LFENLEQRGV   
   201 GIQYKQNVLD IKKQKSGAWL VKVKDLETNE TTTYESDFVF IGAGGASLPL   
   251 LQKTGIKQSK HIGGFPVSGL FLRCTNQEVI DRHHAKVYGK AAVGAPPMSV   
   301 PHLDTRFVDG KRSLLFGPFA GFSPKFLKTG SHMDLIKSVK PNNIVTMLSA   
   351 GIKEMSLTKY LVSQLMLSND ERMDDLRVFF PNAKNEDWEV ITAGQRVQVI   
   401 KDTEDSKGNL QFGTEVITSD DGTLAALLGA SPGASTAVDI MFDVLQRCYR   
   451 DEFKGWEPKI KEMVPSFGYR LTDHEDLYHK INEEVTKYLQ VK  
 
 
 
 
 
 
  
    
  
  
         
  
  
Mass Spectrometry Unit   
Assay Report:  UniMS184/16   
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Report number 2  
Protein sequence coverage:  
  
Sample MQ02  
  
MASCOT SEARCH RESULTS  
  
PROTEIN VIEW 
  
Match to: DLDH_ECOL6 Score: 887 Expect: 1.1e-083  
Dihydrolipoyl dehydrogenase OS=Escherichia coli O6:H1 (strain CFT073 
/ ATCC 700928 / UPEC) GN=lpdA PE=3 SV=2  
  
Nominal mass (Mr): 50657; Calculated pI value: 5.79  
  
Variable modifications: Carbamidomethyl (C),Deamidated (NQ),Gln-
>pyro-Glu  
(N-term Q),Oxidation (M)  
Cleavage by Trypsin: cuts C-term side of KR unless next residue is P 
Sequence Coverage: 54%  
  
Matched peptides shown in Bold Red  
  
  1 MSTEIKTQVV VLGAGPAGYS AAFRCADLGL ETVIVERYNT LGGVCLNVGC       
 51 IPSKALLHVA KVIEEAKALA EHGIVFGEPK TDIDKIRTWK EKVINQLTGG 
101 LAGMAKGRKV KVVNGLGKFT GANTLEVEGE NGKTVINFDN AIIAAGSRPI 
151 QLPFIPHEDP RIWDSTDALE LKEVPERLLV MGGGIIGLEM GTVYHALGSQ 
201 IDVVEMFDQV IPAADKDIVK VFTKRISKKF NLMLETKVTA VEAKEDGIYV 
251 TMEGKKAPAE PQRYDAVLVA IGRVPNGKNL DAGKAGVEVD DRGFIRVDKQ     
301 LRTNVPHIFA IGDIVGQPML AHKGVHEGHV AAEVIAGKKH YFDPKVIPSI     
351 AYTEPEVAWV GLTEKEAKEK GISYETATFP WAASGRAIAS DCADGMTKLI 
401 FDKESHRVIG GAIVGTNGGE LLGEIGLAIE MGCDAEDIAL TIHAHPTLHE 
451 SVGLAAEVFE GSITDLPNPK AKKK  
 
  
    
  
  
         
  
  
Mass Spectrometry Unit   
Assay Report:  UniMS 11 4 /1 7   
